{ "instance": { "nept-20220630.htm": { "axisCustom": 0, "axisStandard": 27, "contextCount": 276, "dts": { "calculationLink": { "local": [ "nept-20220630_cal.xml" ] }, "definitionLink": { "local": [ "nept-20220630_def.xml" ] }, "inline": { "local": [ "nept-20220630.htm" ] }, "labelLink": { "local": [ "nept-20220630_lab.xml" ] }, "presentationLink": { "local": [ "nept-20220630_pre.xml" ] }, "schema": { "local": [ "nept-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 870, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 10, "http://xbrl.sec.gov/dei/2022": 6, "total": 16 }, "keyCustom": 106, "keyStandard": 229, "memberCustom": 42, "memberStandard": 31, "nsprefix": "nept", "nsuri": "http://www.neptunewellness.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Significant accounting policies", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPolicies", "shortName": "Significant accounting policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Inventories", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Property, Plant and Equipment", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Goodwill", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:DisclosureOfProvisionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Provisions", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisions", "shortName": "Provisions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:DisclosureOfProvisionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Liability Related to Warrants", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrants", "shortName": "Liability Related to Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Loans and Borrowings", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowings", "shortName": "Loans and Borrowings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Capital and other components of equity", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquity", "shortName": "Capital and other components of equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Non-controlling Interest", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterest", "shortName": "Non-controlling Interest", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Share-based Payment", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPayment", "shortName": "Share-based Payment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Interim Balance Sheets (Unaudited)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Interim Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Loss Per Share", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLossPerShare", "shortName": "Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Fair Value", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Commitments and Contingencies", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Operating Segments", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegments1", "shortName": "Operating Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Related Parties", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureRelatedParties", "shortName": "Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Subsequent Events", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Significant accounting policies (Policies)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies", "shortName": "Significant accounting policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Basis of Preparation (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationTables", "shortName": "Basis of Preparation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Inventories (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:GoodwillAllocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Goodwill (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:GoodwillAllocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Condensed Consolidated Interim Balance Sheets (Unaudited) (Parenthetical)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnauditedParenthetical", "shortName": "Condensed Consolidated Interim Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Liability Related to Warrants (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsTables", "shortName": "Liability Related to Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Loans and Borrowings (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsTables", "shortName": "Loans and Borrowings (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Capital and other components of equity (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityTables", "shortName": "Capital and other components of equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "us-gaap:MinorityInterestDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Non-controlling Interest (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestTables", "shortName": "Non-controlling Interest (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:MinorityInterestDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Share-based Payment (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables", "shortName": "Share-based Payment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Fair Value (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Operating Segments (Tables)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsTables", "shortName": "Operating Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Reporting Entity - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "shortName": "Reporting Entity - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "nept:ReportingEntityTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "-5", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Basis of Preparation - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails", "shortName": "Basis of Preparation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Basis of Preparation - Schedule of Major Classes of Assets and Liabilities Classified as Held for Sale (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails", "shortName": "Basis of Preparation - Schedule of Major Classes of Assets and Liabilities Classified as Held for Sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited", "shortName": "Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "lang": null, "name": "nept:RoyaltyRevenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_9806f89e-99bd-4819-8517-f8b6c3888351", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_9806f89e-99bd-4819-8517-f8b6c3888351", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_d76a75df-d7d5-488c-a6cc-a85a7d959d3d", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Business Combination - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "shortName": "Business Combination - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Business Combination - Summary of Final Purchase Price Allocation of Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "Business Combination - Summary of Final Purchase Price Allocation of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R43": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_d76a75df-d7d5-488c-a6cc-a85a7d959d3d", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Business Combination - Summary of Final Purchase Price Allocation of Assets Acquired and Liabilities Assumed (Parenthetical) (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "shortName": "Business Combination - Summary of Final Purchase Price Allocation of Assets Acquired and Liabilities Assumed (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "nept:TradeAndOtherReceivablesCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Trade and Other Receivables - Summary of Trade and Other Receivables (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails", "shortName": "Trade and Other Receivables - Summary of Trade and Other Receivables (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Inventories - Summary of Inventories (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails", "shortName": "Inventories - Summary of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Inventories - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesAdditionalInformationDetails", "shortName": "Inventories - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_83a2eed8-87ef-44cc-bcf7-79d2f005ed00", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Property, Plant and Equipment - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails", "shortName": "Property, Plant and Equipment - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_83a2eed8-87ef-44cc-bcf7-79d2f005ed00", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Leases - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "shortName": "Leases - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Leases - Summary of Lease Liabilities Amounts Recognized in Consolidated Balance Sheets (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails", "shortName": "Leases - Summary of Lease Liabilities Amounts Recognized in Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ExciseAndSalesTaxes", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) (Parenthetical)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical", "shortName": "Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ExciseAndSalesTaxes", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Goodwill - Summary of Aggregate Amount of Goodwill is Allocated to Each Reporting Unit (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails", "shortName": "Goodwill - Summary of Aggregate Amount of Goodwill is Allocated to Each Reporting Unit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:GoodwillAllocationTableTextBlock", "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_6febea2f-7548-4f3c-83a0-4c8663114c12", "decimals": "0", "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "nept:TradeAndOtherPayablesCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Trade and Other Payables - Summary of Trade and Other Payables (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails", "shortName": "Trade and Other Payables - Summary of Trade and Other Payables (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_89b6ab42-e431-4a92-928c-4913bffab7cd", "decimals": "2", "first": true, "lang": null, "name": "nept:AnnualRoyaltiesPercentageOfSalesAndOtherRevenue", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Provisions - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails", "shortName": "Provisions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_89b6ab42-e431-4a92-928c-4913bffab7cd", "decimals": "2", "first": true, "lang": null, "name": "nept:AnnualRoyaltiesPercentageOfSalesAndOtherRevenue", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "INF", "first": true, "lang": null, "name": "nept:ClassOfWarrantOrRightNumberOfWarrantsIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Liability Related to Warrants - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "shortName": "Liability Related to Warrants - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "lang": null, "name": "nept:ResidualAmountAllocated", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_be80ff36-d14d-4a56-ade8-5507ffd5133e", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Liability Related to Warrants - Summary of Changes in Value of Liability Related to Warrants (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "shortName": "Liability Related to Warrants - Summary of Changes in Value of Liability Related to Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "lang": null, "name": "nept:RevaluationOfWarrants", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Liability Related to Warrants - Summary of Outstanding Warrants (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "shortName": "Liability Related to Warrants - Summary of Outstanding Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfOutstandingWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "lang": null, "name": "nept:ClassOfWarrantOrRightExercisable", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_be80ff36-d14d-4a56-ade8-5507ffd5133e", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Liability Related to Warrants - Summary of Reconciliation of Changes in Fair Value of Warrants (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails", "shortName": "Liability Related to Warrants - Summary of Reconciliation of Changes in Fair Value of Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfReconciliationOfChangesInFairValueOfWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_b72da186-509b-4906-8c23-5ada9a766487", "decimals": "0", "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfFairValueOfDerivativeWarrantLiabilitiesMeasurementInputsAndValuationTechniquesTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_3b03bdcf-994f-4af3-b349-57d440da2b28", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Liability Related to Warrants - Summary of Fair Value of Derivative Warrant Liabilities Estimated Using Black-Scholes Option Pricing Model (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "shortName": "Liability Related to Warrants - Summary of Fair Value of Derivative Warrant Liabilities Estimated Using Black-Scholes Option Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfFairValueOfDerivativeWarrantLiabilitiesMeasurementInputsAndValuationTechniquesTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_3b03bdcf-994f-4af3-b349-57d440da2b28", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Loans and Borrowings - Summary of Loans and Borrowings (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "shortName": "Loans and Borrowings - Summary of Loans and Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_5eb273ab-d3ab-44a7-9863-4807b5ea9b19", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Loans and Borrowings - Summary of Loans and Borrowings (Parenthetical) (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails", "shortName": "Loans and Borrowings - Summary of Loans and Borrowings (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_c431bada-a9fe-4cf7-8be1-519d8e034e31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited", "shortName": "Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_dd31dad6-1937-475f-b918-dfba0ae30183", "decimals": "0", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100820 - Disclosure - Loans and Borrowings - Summary of Loans and Borrowings - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsAdditionalInformationDetails", "shortName": "Loans and Borrowings - Summary of Loans and Borrowings - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100830 - Disclosure - Capital and Other Components of Equity - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "shortName": "Capital and Other Components of Equity - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfOutstandingWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100840 - Disclosure - Capital and Other Components of Equity - Summary of Changes in Value of Equity (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "shortName": "Capital and Other Components of Equity - Summary of Changes in Value of Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_01834f36-757b-4364-80c4-658d93eb001c", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "div", "nept:LiabilityRelatedToWarrantsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100850 - Disclosure - Capital and Other Components of Equity - Summary of Warrants (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "shortName": "Capital and Other Components of Equity - Summary of Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_1b546344-9401-474c-8821-050ab9c6855b", "decimals": "0", "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_68d55531-c6e2-4e42-be75-4527e56af869", "decimals": "INF", "first": true, "lang": null, "name": "nept:NumberOfWarrantsGranted", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100860 - Disclosure - Capital and Other Components of Equity - Summary of Warrants (Parenthetical) (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "shortName": "Capital and Other Components of Equity - Summary of Warrants (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_68d55531-c6e2-4e42-be75-4527e56af869", "decimals": "INF", "first": true, "lang": null, "name": "nept:NumberOfWarrantsGranted", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100870 - Disclosure - Non-controlling Interest - Summarized Statement of Loss and Comprehensive Loss (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "shortName": "Non-controlling Interest - Summarized Statement of Loss and Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "div", "us-gaap:MinorityInterestDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_5a13ef3d-32c2-4be5-b579-ec9a5e72db5f", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100880 - Disclosure - Non-controlling Interest - Summarized Statement of Balance Sheets (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "shortName": "Non-controlling Interest - Summarized Statement of Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "div", "us-gaap:MinorityInterestDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_0e2025ef-ca37-42be-a6b3-5d5fc5cc8a33", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100890 - Disclosure - Non-controlling Interest - Summarized Statement of Cash Flow (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "shortName": "Non-controlling Interest - Summarized Statement of Cash Flow (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "div", "us-gaap:MinorityInterestDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_5a13ef3d-32c2-4be5-b579-ec9a5e72db5f", "decimals": "0", "lang": null, "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100900 - Disclosure - Share-based Payment - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "shortName": "Share-based Payment - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_208b8c6a-c9e6-41c8-a7f7-007a1bc2a208", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100910 - Disclosure - Share-based Payment - Summary of Stock Option Plan (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails", "shortName": "Share-based Payment - Summary of Stock Option Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_208b8c6a-c9e6-41c8-a7f7-007a1bc2a208", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Interim Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "lang": null, "name": "nept:DepreciationOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_2014d09e-17b7-4655-b6a9-12571bb5110a", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100920 - Disclosure - Share-based Payment - Schedule of Number and Contractual Life of Options (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails", "shortName": "Share-based Payment - Schedule of Number and Contractual Life of Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_2014d09e-17b7-4655-b6a9-12571bb5110a", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_84e46fd0-c91a-40d0-896f-ef74612d854b", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100940 - Disclosure - Share-based Payment - Summary of Number and Weighted Average Exercise Prices of Market Performance Options (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "shortName": "Share-based Payment - Summary of Number and Weighted Average Exercise Prices of Market Performance Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_84e46fd0-c91a-40d0-896f-ef74612d854b", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfShareBasedCompensationDeferredStockUnitsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_cab1f4ff-97e0-4448-a95e-d9bd85ec6181", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100950 - Disclosure - Share-based Payment - Summary of Number and Weighted Average Share Prices of DSUs (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "shortName": "Share-based Payment - Summary of Number and Weighted Average Share Prices of DSUs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "nept:ScheduleOfShareBasedCompensationDeferredStockUnitsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_cab1f4ff-97e0-4448-a95e-d9bd85ec6181", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_115be564-63b0-447a-a34b-fa492dd8938d", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100960 - Disclosure - Share-based Payment - Summary of Number and Weighted Average Share Prices of RSUs (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails", "shortName": "Share-based Payment - Summary of Number and Weighted Average Share Prices of RSUs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_115be564-63b0-447a-a34b-fa492dd8938d", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UsdPerShare", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "nept:FinanceIncome", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100980 - Disclosure - Finance Income and Finance Costs - Summary of Finance Income (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails", "shortName": "Finance Income and Finance Costs - Summary of Finance Income (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "nept:FinanceCosts", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100990 - Disclosure - Finance Income and Finance Costs - Summary of Finance Costs (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails", "shortName": "Finance Income and Finance Costs - Summary of Finance Costs (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_ecdfd8d1-94e0-4427-a397-e156568148f1", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101000 - Disclosure - Income Taxes - Schedule of Income Tax (Recovery) Expense (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxRecoveryExpenseDetails", "shortName": "Income Taxes - Schedule of Income Tax (Recovery) Expense (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R77": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101010 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Tax Rate (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails", "shortName": "Income Taxes - Schedule of Reconciliation of Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R78": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_f42b4fe4-2cdf-4881-a38a-c315128fd4e1", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101090 - Disclosure - Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_f42b4fe4-2cdf-4881-a38a-c315128fd4e1", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101100 - Disclosure - Fair Value - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "shortName": "Fair Value - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:ReportingEntityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Reporting Entity", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntity", "shortName": "Reporting Entity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "nept:ReportingEntityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_8443b826-ff5b-4a34-9696-19cc258d4a58", "decimals": null, "first": true, "lang": "en-US", "name": "nept:TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialtyIngredient", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101110 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_8443b826-ff5b-4a34-9696-19cc258d4a58", "decimals": null, "first": true, "lang": "en-US", "name": "nept:TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialtyIngredient", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101120 - Disclosure - Operating Segments - Summary of Revenue Attributed to Geographical Locations (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails", "shortName": "Operating Segments - Summary of Revenue Attributed to Geographical Locations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_3e94081a-3923-4e20-8a87-e3e3d0138171", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R82": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "101130 - Disclosure - Operating Segments - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails", "shortName": "Operating Segments - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R83": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101140 - Disclosure - Operating Segments - Summary of Long-Lived Assets by Geographical Location (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "shortName": "Operating Segments - Summary of Long-Lived Assets by Geographical Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_6d9e6812-dd86-436a-82f4-cd8e53912832", "decimals": "0", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101150 - Disclosure - Operating Segments - Summary of Assets Held for Sale (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "shortName": "Operating Segments - Summary of Assets Held for Sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_6d9e6812-dd86-436a-82f4-cd8e53912832", "decimals": "0", "lang": null, "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101160 - Disclosure - Operating Segments - Summary of Revenue Derived from Sale of Goods (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails", "shortName": "Operating Segments - Summary of Revenue Derived from Sale of Goods (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_cd40b55e-4be1-444d-8cb5-2719b34c2b03", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101170 - Disclosure - Related Parties - Additional Information (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "shortName": "Related Parties - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_7f9c962b-4d1a-4b7b-b221-da041e729ab4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101180 - Disclosure - Subsequent Event (Additional Information) (Details)", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "shortName": "Subsequent Event (Additional Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_51f2bfcf-9621-44b9-ad58-85f52e04d97e", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Basis of Preparation", "role": "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparation1", "shortName": "Basis of Preparation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nept-20220630.htm", "contextRef": "C_34c07af0-55c8-4de9-9179-0eeb72567f81", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 77, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r720" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "nept_AccruedAndOtherReceivablesCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": 2.0, "parentTag": "nept_TradeAndOtherReceivablesCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued and other receivables current.", "label": "Accrued And Other Receivables Current", "terseLabel": "Accrued and other receivables" } } }, "localname": "AccruedAndOtherReceivablesCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "nept_AccruedLiabilitiesAndOtherPayables": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": { "order": 1.0, "parentTag": "nept_TradeAndOtherPayablesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued liabilities and other payables.", "label": "Accrued Liabilities And Other Payables", "terseLabel": "Accrued liabilities and other payables" } } }, "localname": "AccruedLiabilitiesAndOtherPayables", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "nept_AdditionalMinimumGuaranteedPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional minimum guaranteed payments.", "label": "Additional Minimum Guaranteed Payments", "terseLabel": "Additional minimum guaranteed payments" } } }, "localname": "AdditionalMinimumGuaranteedPayments", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_AgreementAdditionalExtendingTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Additional Extending Term.", "label": "Agreement Additional Extending Term", "terseLabel": "Agreement additional extending term" } } }, "localname": "AgreementAdditionalExtendingTerm", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_AmendedPromissoryNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Promissory Notes [Member]", "label": "Amended Promissory Notes [Member]", "terseLabel": "Amended Promissory Notes" } } }, "localname": "AmendedPromissoryNotesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_AmortizationOfDiscountOrPremiumOnWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of discount or premium on warrants issued.", "label": "Amortization Of Discount Or Premium On Warrants Issued", "terseLabel": "Amortization of the discount or premium on warrants issued" } } }, "localname": "AmortizationOfDiscountOrPremiumOnWarrantsIssued", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_AnnualExpenseOfContractForSecurityOfSite": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Annual expense of contract for security of site.", "label": "Annual Expense Of Contract For Security Of Site", "terseLabel": "Annual expense of contract for security of the site" } } }, "localname": "AnnualExpenseOfContractForSecurityOfSite", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_AnnualRoyaltiesPercentageOfSalesAndOtherRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual royalties percentage of sales and other revenue.", "label": "Annual Royalties Percentage of Sales and Other Revenue", "terseLabel": "Annual royalties percentage of sales and other revenue" } } }, "localname": "AnnualRoyaltiesPercentageOfSalesAndOtherRevenue", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_AreaOfFacilityLocated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of facility located.", "label": "Area Of Facility Located", "terseLabel": "Area of facility located" } } }, "localname": "AreaOfFacilityLocated", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "areaItemType" }, "nept_AssetsHeldForSalePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets held for sale policy.", "label": "Assets Held for Sale Policy [Policy Text Block]", "terseLabel": "Assets held for sale" } } }, "localname": "AssetsHeldForSalePolicyPolicyTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nept_AtTheMarketOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At-The-Market offering.", "label": "At The Market Offering [Member]", "terseLabel": "At-The-Market Offering" } } }, "localname": "AtTheMarketOfferingMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_BiodrogaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biodroga.", "label": "Biodroga [Member]", "terseLabel": "Biodroga" } } }, "localname": "BiodrogaMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails" ], "xbrltype": "domainItemType" }, "nept_BlackScholesModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Black-Scholes model.", "label": "Black-Scholes model [Member]", "terseLabel": "Black-Scholes Model" } } }, "localname": "BlackScholesModelMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_BuildingAndBuildingComponentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Building and building components.", "label": "Building And Building Components [Member]", "terseLabel": "Building and Building Components" } } }, "localname": "BuildingAndBuildingComponentsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_BusinessAcquisitionPreConsolidationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition pre-consolidation shares.", "label": "Business acquisition pre-consolidation shares", "terseLabel": "Pre-consolidation shares" } } }, "localname": "BusinessAcquisitionPreConsolidationShares", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination, recognized identifiable assets acquired and liabilities assumed, right-of-use asset.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Asset", "terseLabel": "Right-of-use asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "nept_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination step acquisition equity interest in acquiree, discount rate.", "label": "Business Combination Step Acquisition Equity Interest In Acquiree Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeDiscountRate", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueOfAssetRemeasured": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination step acquisition equity interest in acquiree fair value of asset remeasured.", "label": "Business Combination Step Acquisition Equity Interest In Acquiree Fair Value Of Asset Remeasured", "terseLabel": "Fair value of asset remeasured" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueOfAssetRemeasured", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_CanadianCannabisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canadian cannabis.", "label": "Canadian cannabis [Member]", "verboseLabel": "Canadian Cannabis" } } }, "localname": "CanadianCannabisMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_CannabisAndHempProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cannabis and hemp products.", "label": "Cannabis and Hemp Products [Member]", "terseLabel": "Cannabis and Hemp Products" } } }, "localname": "CannabisAndHempProductsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "nept_CannabisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cannabis.", "label": "Cannabis [Member]", "terseLabel": "Cannabis" } } }, "localname": "CannabisMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liability.", "label": "Change In Fair Value Of Warrant Liability", "terseLabel": "Change in fair value of warrant liability", "verboseLabel": "Change in fair value" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_ChangeInRevaluationOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in revaluation of marketable securities.", "label": "Change In Revaluation Of Marketable Securities", "negatedLabel": "Change in revaluation of marketable securities", "terseLabel": "Change in revaluation of marketable securities" } } }, "localname": "ChangeInRevaluationOfMarketableSecurities", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_ClassOfWarrantOrRightExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "Class Of Warrant Or Right Exercisable", "terseLabel": "Number of warrants exercisable" } } }, "localname": "ClassOfWarrantOrRightExercisable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "nept_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right exercisable weighted average exercise price.", "label": "Class of Warrant or Right Exercisable Weighted Average Exercise Price", "terseLabel": "Warrants exercisable, Weighted average exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails" ], "xbrltype": "perShareItemType" }, "nept_ClassOfWarrantOrRightNumberOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of warrants exercised.", "label": "Class Of Warrant Or Right Number Of Warrants Exercised", "negatedLabel": "Warrants exercised during the year", "terseLabel": "Number of warrants exercised" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsExercised", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails" ], "xbrltype": "sharesItemType" }, "nept_ClassOfWarrantOrRightNumberOfWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of warrants issued.", "label": "Class Of Warrant Or Right Number Of Warrants Issued", "terseLabel": "Number of warrants issued", "verboseLabel": "Warrants issued during the year" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails" ], "xbrltype": "sharesItemType" }, "nept_CombinedOfferingPriceOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combined offering price of warrants.", "label": "Combined Offering Price Of Warrants", "terseLabel": "Combined offering price of warrants" } } }, "localname": "CombinedOfferingPriceOfWarrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "nept_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares.", "label": "Common Shares [Member]", "terseLabel": "Common Shares" } } }, "localname": "CommonSharesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_CommonWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common warrant.", "label": "Common Warrant [Member]", "terseLabel": "Common Warrant" } } }, "localname": "CommonWarrantMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_ComparativeFiguresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Comparative figures.", "label": "Comparative Figures [Abstract]" } } }, "localname": "ComparativeFiguresAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_ContributionsByAndDistributionToEquityHoldersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contributions by and distribution to equity holders.", "label": "Contributions By And Distribution To Equity Holders [Abstract]", "terseLabel": "Contributions by and distribution to equity holders" } } }, "localname": "ContributionsByAndDistributionToEquityHoldersAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "stringItemType" }, "nept_CostOfServices": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_CostOfGoodsAndServicesSold", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of services.", "label": "Cost of Services", "negatedLabel": "Cost of services" } } }, "localname": "CostOfServices", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer one.", "label": "Customer One Member", "terseLabel": "Customer One" } } }, "localname": "CustomerOneMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_DeferredIncomeTaxAssetsLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred income tax assets liabilities.", "label": "Deferred Income Tax Assets Liabilities", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "DeferredIncomeTaxAssetsLiabilities", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "nept_DeferredShareUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred share units.", "label": "Deferred Share Units [Member]", "terseLabel": "DSUs" } } }, "localname": "DeferredShareUnitsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails" ], "xbrltype": "domainItemType" }, "nept_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax expense (income) recognised in profit or loss.", "label": "Deferred Tax Expense Income Recognised In Profit Or Loss", "negatedLabel": "Recognized in net income" } } }, "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "nept_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities Right-of-use assets.", "label": "Deferred tax liabilities Right-of-use assets", "negatedLabel": "Right-of-use assets", "terseLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "nept_DepreciationOfPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Depreciation of property, plant and equipment.", "label": "Depreciation Of Property Plant And Equipment", "terseLabel": "Depreciation of property, plant and equipment" } } }, "localname": "DepreciationOfPropertyPlantAndEquipment", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_DescriptionOfVestingRequirementsForShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of vesting requirements for share-based payment arrangement.", "label": "Description Of Vesting Requirements For Share Based Payment Arrangement", "terseLabel": "Description of vesting requirements for share-based payment arrangement" } } }, "localname": "DescriptionOfVestingRequirementsForShareBasedPaymentArrangement", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "stringItemType" }, "nept_DirectOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Direct offering.", "label": "Direct Offering [Member]", "terseLabel": "Direct Offering" } } }, "localname": "DirectOfferingMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "nept_DisclosureOfBasisOfPreparationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of basis of preparation abstract.", "label": "Disclosure Of Basis Of Preparation [Abstract]" } } }, "localname": "DisclosureOfBasisOfPreparationAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_DisclosureOfComparativeFiguresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Comparative figures,", "label": "Disclosure Of Comparative Figures [Text Block]", "terseLabel": "Comparative figures" } } }, "localname": "DisclosureOfComparativeFiguresTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureComparativeFigures" ], "xbrltype": "textBlockItemType" }, "nept_DisclosureOfProvisionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of provisions.", "label": "Disclosure Of Provisions [Abstract]" } } }, "localname": "DisclosureOfProvisionsAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_DisclosureOfProvisionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of provisions.", "label": "Disclosure Of Provisions [Text Block]", "terseLabel": "Provisions" } } }, "localname": "DisclosureOfProvisionsTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisions" ], "xbrltype": "textBlockItemType" }, "nept_DisposalGroupIncludingDiscontinuedOperationBuildingAndBuildingComponentsCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, building and building components, current.", "label": "Disposal Group, Including Discontinued Operation, Building and building components, Current", "terseLabel": "Building and building components" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationBuildingAndBuildingComponentsCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "nept_DisposalGroupIncludingDiscontinuedOperationLaboratoryAndPlantEquipmentCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, laboratory and plant equipment, current.", "label": "Disposal Group, Including Discontinued Operation, Laboratory and plant equipment, Current", "terseLabel": "Laboratory and plant equipment" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationLaboratoryAndPlantEquipmentCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "nept_DisposalGroupIncludingDiscontinuedOperationProvisionsCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation provisions current.", "label": "Disposal Group, Including Discontinued Operation provisions current", "terseLabel": "Provisions", "verboseLabel": "Liabilities directly associated with assets held for sale, provision" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationProvisionsCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees.", "label": "Employees [Member]", "terseLabel": "Employees" } } }, "localname": "EmployeesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_EquityBasedShareAwardsLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity based share awards Liability", "label": "Equity based share awards Liability", "verboseLabel": "Equity based share awards liability" } } }, "localname": "EquityBasedShareAwardsLiability", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ExercisePriceRangeEightyTwoPointSixOneToOneHundredEightyOnePointSixFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range eighty two point six one to one hundred eighty one point six five.", "label": "Exercise Price Range Eighty Two Point Six One To One Hundred Eighty One Point Six Five [Member]", "verboseLabel": "$82.61 - $181.65" } } }, "localname": "ExercisePriceRangeEightyTwoPointSixOneToOneHundredEightyOnePointSixFiveMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeFiftyFivePointFourThreeToNinetyTwoPointThreeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range fifty five point four three to ninety two point three six.", "label": "Exercise price range fifty five point four three to ninety two point three six [member]", "terseLabel": "$55.43 - $92.36" } } }, "localname": "ExercisePriceRangeFiftyFivePointFourThreeToNinetyTwoPointThreeSixMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeFortyThreePointFourZeroToSixtySixPointEightFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range forty three point four zero to sixty six point eight five.", "label": "Exercise Price Range Forty Three Point Four Zero To Sixty Six Point Eight Five [Member]", "verboseLabel": "$43.40 - $66.85" } } }, "localname": "ExercisePriceRangeFortyThreePointFourZeroToSixtySixPointEightFiveMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeHundredAndSixPointThreeFourToTwoHundredAndThirtyThreePointEightFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range hundred and six point three four to two hundred and thirty three point eight four.", "label": "Exercise price range hundred and six point three four to two hundred and thirty three point eight four [member]", "terseLabel": "$106.34 - $233.84" } } }, "localname": "ExercisePriceRangeHundredAndSixPointThreeFourToTwoHundredAndThirtyThreePointEightFourMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeNinetyTwoPointThreeSevenToHundredAndSixPointThreeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range ninety two point three seven to hundred and six point three three.", "label": "Exercise price range ninety two point three seven to hundred and six point three three [member]", "terseLabel": "$92.37 - $106.33" } } }, "localname": "ExercisePriceRangeNinetyTwoPointThreeSevenToHundredAndSixPointThreeThreeMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeOneHundredEightyOnePointSixSixToTwoHundredThirtyTwoPointSevenFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range one hundred eighty one point six six to two hundred thirty two point seven five.", "label": "Exercise Price Range One Hundred Eighty One Point Six Six To Two Hundred Thirty Two Point Seven Five [Member]", "verboseLabel": "$181.66 - $232.75" } } }, "localname": "ExercisePriceRangeOneHundredEightyOnePointSixSixToTwoHundredThirtyTwoPointSevenFiveMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeSeventeenPointFiveSevenToFiftyFivePointFourTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range seventeen point five seven to fifty five point four two.", "label": "Exercise price range seventeen point five seven to fifty five point four two [member]", "terseLabel": "$17.57 - $55.42" } } }, "localname": "ExercisePriceRangeSeventeenPointFiveSevenToFiftyFivePointFourTwoMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeSeventyOnePointSevenSixToEightyTwoPointSixZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range seventy one point seven six to eighty two point six zero.", "label": "Exercise Price Range Seventy One Point Seven Six To Eighty Two Point Six Zero [Member]", "verboseLabel": "$71.76 - $82.60" } } }, "localname": "ExercisePriceRangeSeventyOnePointSevenSixToEightyTwoPointSixZeroMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeSixtySixPointEightSixToSeventyOnePointSevenFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range sixty six point eight six to seventy one point seven five.", "label": "Exercise Price Range Sixty Six Point Eight Six To Seventy One Point Seven Five [Member]", "verboseLabel": "$66.86 - $71.75" } } }, "localname": "ExercisePriceRangeSixtySixPointEightSixToSeventyOnePointSevenFiveMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExercisePriceRangeTwoHundredAndThirtyThreePointEightFiveToTwoHundredAndSeventyFourPointThreeNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price range two hundred and thirty three point eight five to two hundred and seventy four point three nine.", "label": "Exercise price range two hundred and thirty three point eight five to two hundred and seventy four point three nine [member]", "terseLabel": "$233.85 - $274.39" } } }, "localname": "ExercisePriceRangeTwoHundredAndThirtyThreePointEightFiveToTwoHundredAndSeventyFourPointThreeNineMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "nept_ExpectedCreditLosses": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expected credit losses.", "label": "Expected Credit Losses", "terseLabel": "Expected credit losses" } } }, "localname": "ExpectedCreditLosses", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_FederalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal.", "label": "Federal [Member]", "terseLabel": "Federal" } } }, "localname": "FederalMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_FinanceCosts": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance costs.", "label": "Finance Costs", "negatedLabel": "Finance costs", "negatedTotalLabel": "Finance costs", "totalLabel": "Finance costs" } } }, "localname": "FinanceCosts", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_FinanceIncome": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance income.", "label": "Finance Income", "terseLabel": "Finance income", "totalLabel": "Finance income" } } }, "localname": "FinanceIncome", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_FinanceIncomeAndFinanceCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Income And Finance Costs [Abstract]" } } }, "localname": "FinanceIncomeAndFinanceCostsAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_FinanceIncomeAndFinanceCostsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance income and finance costs.", "label": "Finance Income And Finance Costs [Text Block]", "terseLabel": "Finance Income and Finance Costs" } } }, "localname": "FinanceIncomeAndFinanceCostsTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCosts" ], "xbrltype": "textBlockItemType" }, "nept_FinanceIncomeCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance income (costs).", "label": "Finance income (costs)" } } }, "localname": "FinanceIncomeCosts", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "nept_FinancingReceivableCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing receivable current.", "label": "Financing Receivable Current [Member]", "terseLabel": "Current" } } }, "localname": "FinancingReceivableCurrentMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "domainItemType" }, "nept_FinancingReceivables0To30DaysPastDueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Past due 0-30 days.", "label": "Financing Receivables0 To30 Days Past Due [Member]", "terseLabel": "Past due 0-30 days" } } }, "localname": "FinancingReceivables0To30DaysPastDueMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "domainItemType" }, "nept_FinancingReceivables31To120DaysPastDueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Past due 31-120 days.", "label": "Financing Receivables31 To120 Days Past Due [Member]", "terseLabel": "Past due 31-120 days" } } }, "localname": "FinancingReceivables31To120DaysPastDueMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "domainItemType" }, "nept_FiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five years.", "label": "Five Years [Member]", "terseLabel": "5 years" } } }, "localname": "FiveYearsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_FoodAndBeverageProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food and beverage products.", "label": "Food and Beverage Products [Member]", "terseLabel": "Food and Beverage Products" } } }, "localname": "FoodAndBeverageProductsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "nept_FormerControllingShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former controlling shareholder.", "label": "Former Controlling Shareholder [Member]", "terseLabel": "Former Controlling Shareholder" } } }, "localname": "FormerControllingShareholderMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_GoodwillAllocationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodwill allocation.", "label": "Goodwill Allocation Table [Text Block]", "terseLabel": "Summary of Aggregate Amount of Goodwill is Allocated to Each Reporting Unit" } } }, "localname": "GoodwillAllocationTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillTables" ], "xbrltype": "textBlockItemType" }, "nept_GrantsAndSubsidiesReceivablesCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": 4.0, "parentTag": "nept_TradeAndOtherReceivablesCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Grants and subsidies receivables current.", "label": "Grants And Subsidies Receivables Current", "terseLabel": "Grants and subsidies receivables" } } }, "localname": "GrantsAndSubsidiesReceivablesCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncomeTaxReconciliationPermanentDifferenceRelatedToDerivative": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation permanent difference related to derivative.", "label": "Income tax reconciliation permanent difference related to derivative", "terseLabel": "Permanent difference related to derivative" } } }, "localname": "IncomeTaxReconciliationPermanentDifferenceRelatedToDerivative", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_IncreaseDecreaseInOperatingAssetsAndLiabilities": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating assets and liabilities", "label": "Increase Decrease In Operating Assets and liabilities", "negatedTerseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAndLiabilities", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseInProvisions": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in provisions.", "label": "Increase Decrease In Provisions", "terseLabel": "Provisions" } } }, "localname": "IncreaseDecreaseInProvisions", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseInRightOfUse": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in right of use.", "label": "Increase Decrease In Right Of Use", "terseLabel": "Right of Use" } } }, "localname": "IncreaseDecreaseInRightOfUse", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseResultingFromReconciliationTaxRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) resulting from reconciliation tax rate.", "label": "Increase Decrease Resulting From Reconciliation Tax Rate [Abstract]", "terseLabel": "Increase (decrease) resulting from:" } } }, "localname": "IncreaseDecreaseResultingFromReconciliationTaxRateAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "stringItemType" }, "nept_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) through business combinations, deferred tax liability (asset).", "label": "Increase Decrease Through Business Combinations Deferred Tax Liability Asset", "negatedLabel": "Business Acquisition", "terseLabel": "Business Acquisition" } } }, "localname": "IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) through net exchange differences, deferred tax liability (asset).", "label": "Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset", "negatedLabel": "Foreign exchange effect", "terseLabel": "Foreign exchange effect" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease through restricted share units released net of withholding taxes.", "label": "Increase Decrease Through Restricted Share Units Released Net Of Withholding Taxes", "terseLabel": "RSUs released, net of withholding taxes" } } }, "localname": "IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxes", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase decrease through restricted share units released net of withholding taxes, shares.", "label": "Increase Decrease Through Restricted Share Units Released Net Of Withholding Taxes Shares", "terseLabel": "RSUs released, net of withholding taxes, shares" } } }, "localname": "IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxesShares", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "sharesItemType" }, "nept_InitialWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial warrant liability.", "label": "Initial Warrant Liability", "terseLabel": "Initial warrant liability" } } }, "localname": "InitialWarrantLiability", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_InnovationProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Innovation Products [Member]", "label": "Innovation Products [Member]", "terseLabel": "Innovation Products" } } }, "localname": "InnovationProductsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "nept_JaneGoodallInstituteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jane goodall institute.", "label": "Jane Goodall Institute [Member]", "terseLabel": "Jane Goodall Institute" } } }, "localname": "JaneGoodallInstituteMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_LaboratoryAndPlantEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Laboratory and plant equipment.", "label": "Laboratory And Plant Equipment [Member]", "terseLabel": "Laboratory, and plant equipment" } } }, "localname": "LaboratoryAndPlantEquipmentMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_LeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease liabilities.", "label": "Lease Liabilities [Member]", "terseLabel": "Lease Liabilities" } } }, "localname": "LeaseLiabilitiesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "nept_LegalProceedingProvisions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Legal Proceedings Provisions", "label": "Legal Proceeding Provisions", "terseLabel": "Legal proceeding provisions" } } }, "localname": "LegalProceedingProvisions", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LesseeOperatingLeaseInitialLeaseTermExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease, initial lease term expiration period.", "label": "Lessee Operating Lease Initial Lease Term Expiration Period", "terseLabel": "Initial lease term expiration period" } } }, "localname": "LesseeOperatingLeaseInitialLeaseTermExpirationPeriod", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "gYearMonthItemType" }, "nept_LesseeOperatingLeaseInitialTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease, initial term of contract.", "label": "Lessee Operating Lease Initial Term Of Contract", "terseLabel": "Initial term of contract" } } }, "localname": "LesseeOperatingLeaseInitialTermOfContract", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "nept_LesseeOperatingLeaseRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease recognized in balance sheet.", "label": "Lessee Operating Lease Recognized In Balance Sheet Table [Text Block]", "terseLabel": "Summary of Lease Liabilities Amounts Recognized in Consolidated Balance Sheets" } } }, "localname": "LesseeOperatingLeaseRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "nept_LiabilityRelatedToLongTermIncentive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability related to this long-term incentive.", "label": "Liability Related To Long Term Incentive", "terseLabel": "Liability related to long-term incentive" } } }, "localname": "LiabilityRelatedToLongTermIncentive", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LiabilityRelatedToWarrantsCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability related to warrants current.", "label": "Liability Related to Warrants Current", "terseLabel": "Liability related to warrants" } } }, "localname": "LiabilityRelatedToWarrantsCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_LiabilityRelatedToWarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for liability related to warrants.", "label": "Liability Related To Warrants Disclosure [Text Block]", "terseLabel": "Liability Related to Warrants" } } }, "localname": "LiabilityRelatedToWarrantsDisclosureTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrants" ], "xbrltype": "textBlockItemType" }, "nept_LicenseAgreementExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License agreement expiry date.", "label": "License Agreement Expiry Date", "terseLabel": "License agreement expiry date" } } }, "localname": "LicenseAgreementExpiryDate", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "nept_LicenseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License agreements.", "label": "License Agreements [Member]", "terseLabel": "License Agreements" } } }, "localname": "LicenseAgreementsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_LitigationRelatedToProvisionForCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation related to provision for currency translation adjustments.", "label": "Litigation Related To Provision For Currency Translation Adjustments", "terseLabel": "Litigation related to provision for currency translation adjustments" } } }, "localname": "LitigationRelatedToProvisionForCurrencyTranslationAdjustments", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LitigationRelatedToProvisionForRoyaltyPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation related to provision for royalty payments.", "label": "Litigation Related To Provision For Royalty Payments", "terseLabel": "Litigation related to provision for royalty payments" } } }, "localname": "LitigationRelatedToProvisionForRoyaltyPayments", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LitigationRelatedToProvisionForRoyaltyPaymentsIncreasedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation related to provision for royalty payments increased amount.", "label": "Litigation Related To Provision For Royalty Payments Increased Amount", "terseLabel": "Litigation related to provision for royalty payments increased amount" } } }, "localname": "LitigationRelatedToProvisionForRoyaltyPaymentsIncreasedAmount", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LongTermCashBonusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term cash bonus.", "label": "Long Term Cash Bonus [Member]", "terseLabel": "Long Term Cash Bonus" } } }, "localname": "LongTermCashBonusMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_LongTermIncentivePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term incentive payable.", "label": "Long Term Incentive Payable", "terseLabel": "Long-term incentive payable" } } }, "localname": "LongTermIncentivePayable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_LonzaAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lonza agreement.", "label": "Lonza Agreement [Member]", "terseLabel": "Lonza Agreement" } } }, "localname": "LonzaAgreementMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_LossPerShareAttributableToEquityHoldersOfCorporationBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss per share attributable to equity holders of the corporation, basic.", "label": "Loss Per Share Attributable To Equity Holders Of Corporation Basic", "terseLabel": "Equity holders of the Corporation, basic" } } }, "localname": "LossPerShareAttributableToEquityHoldersOfCorporationBasic", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "nept_LossPerShareAttributableToEquityHoldersOfCorporationDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss per share attributable to equity holders of the corporation, diluted.", "label": "Loss Per Share Attributable To Equity Holders Of Corporation Diluted", "terseLabel": "Equity holders of the Corporation, diluted" } } }, "localname": "LossPerShareAttributableToEquityHoldersOfCorporationDiluted", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "nept_LossPerShareAttributableToNonControllingInterestBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss per share attributable to non-controlling interest, basic.", "label": "Loss Per Share Attributable To Non Controlling Interest Basic", "terseLabel": "Non-controlling interest, basic" } } }, "localname": "LossPerShareAttributableToNonControllingInterestBasic", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "nept_LossPerShareAttributableToNonControllingInterestDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss per share attributable to non-controlling interest, diluted.", "label": "Loss Per Share Attributable To Non Controlling Interest Diluted", "terseLabel": "Non-controlling interest, diluted" } } }, "localname": "LossPerShareAttributableToNonControllingInterestDiluted", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "nept_MarketCapitalizationAchievedPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market capitalization achieved period.", "label": "Market Capitalization Achieved Period", "terseLabel": "Market capitalization achieved period" } } }, "localname": "MarketCapitalizationAchievedPeriod", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "nept_MarketPerformanceOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market performance options.", "label": "Market Performance Options [Member]", "terseLabel": "Market Performance Options" } } }, "localname": "MarketPerformanceOptionsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "domainItemType" }, "nept_MeasurementOfCallOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Measurement of call option.", "label": "Measurement Of Call Option", "terseLabel": "Measurement of call option." } } }, "localname": "MeasurementOfCallOption", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_MinimumGuaranteedPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum guaranteed payments.", "label": "Minimum Guaranteed Payments", "terseLabel": "Minimum guaranteed payments" } } }, "localname": "MinimumGuaranteedPayments", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_MinimumMarketCapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum market capitalization.", "label": "Minimum Market Capitalization", "terseLabel": "Minimum market capitalization" } } }, "localname": "MinimumMarketCapitalization", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_MoonbugEntertainmentLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Moonbug Entertainment Limited.", "label": "Moonbug Entertainment Limited [Member]", "terseLabel": "Moonbug Entertainment Limited" } } }, "localname": "MoonbugEntertainmentLimitedMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_MovementsInExchangeRatesOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Movements in exchange rates of warrants.", "label": "Movements In Exchange Rates Of Warrants", "terseLabel": "Movements in exchange rates" } } }, "localname": "MovementsInExchangeRatesOfWarrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_NetFinanceExpense": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net finance expense.", "label": "Net Finance Expense", "terseLabel": "Net finance expense" } } }, "localname": "NetFinanceExpense", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_NonDeductibleAndTaxExemptItems": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non deductible and tax exempt items.", "label": "Non Deductible And Tax Exempt Items", "terseLabel": "Non deductible and tax exempt items" } } }, "localname": "NonDeductibleAndTaxExemptItems", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nept_NonEmployeeCompensationRelatedToWarrants": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-employee compensation related to warrants.", "label": "Non Employee Compensation Related To Warrants", "terseLabel": "Non-employee compensation related to warrants" } } }, "localname": "NonEmployeeCompensationRelatedToWarrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_NonMarketPerformanceOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non market performance options.", "label": "Non Market Performance Options [Member]", "terseLabel": "Non-market Performance Options" } } }, "localname": "NonMarketPerformanceOptionsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_NumberOfCovenantsToBeMetForLoansAndBorrowingsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of covenants to be met for loans and borrowings outstanding.", "label": "Number of Covenants to be Met for Loans and Borrowings Outstanding", "terseLabel": "Number of covenants to be met for loans and borrowings outstanding" } } }, "localname": "NumberOfCovenantsToBeMetForLoansAndBorrowingsOutstanding", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "nept_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Customers", "label": "Number of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "nept_NumberOfCustomersAccountedInTradeReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customers accounted in trade receivables.", "label": "Number Of Customers Accounted In Trade Receivables", "terseLabel": "Number of customers accounted in trade receivables" } } }, "localname": "NumberOfCustomersAccountedInTradeReceivables", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "nept_NumberOfInstalmentsInWhichSharesVest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of instalments in which shares vest.", "label": "Number Of Instalments In Which Shares Vest", "terseLabel": "Vesting instalments" } } }, "localname": "NumberOfInstalmentsInWhichSharesVest", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "nept_NumberOfOptionIssuableToOneConsultantPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of option issuable to one consultant percentage of outstanding stock maximum.", "label": "Number of Option Issuable to One Consultant Percentage of Outstanding Stock Maximum", "terseLabel": "Percentage of maximum number of stock options issuable to one consultant" } } }, "localname": "NumberOfOptionIssuableToOneConsultantPercentageOfOutstandingStockMaximum", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_NumberOfOptionIssuableToSingleHolderPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of option issuable to single holder percentage of outstanding stock maximum.", "label": "Number of Option Issuable to Single Holder Percentage of Outstanding Stock Maximum", "terseLabel": "Percentage of maximum number of stock options issuable to single holder" } } }, "localname": "NumberOfOptionIssuableToSingleHolderPercentageOfOutstandingStockMaximum", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_NumberOfOtherEquityInstrumentsWithheldAsPaymentOfWithholdingTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of other equity instruments withheld as payment of withholding taxes.", "label": "Number Of Other Equity Instruments Withheld As Payment Of Withholding Taxes", "terseLabel": "Withheld as payment of withholding taxes" } } }, "localname": "NumberOfOtherEquityInstrumentsWithheldAsPaymentOfWithholdingTaxes", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_NumberOfRenewableOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of renewable option.", "label": "Number Of Renewable Option", "terseLabel": "Number of renewable option" } } }, "localname": "NumberOfRenewableOption", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "nept_NumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable.", "label": "Number Of Warrants Exercisable", "terseLabel": "Number of warrants exercisable" } } }, "localname": "NumberOfWarrantsExercisable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails" ], "xbrltype": "sharesItemType" }, "nept_NumberOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants granted.", "label": "Number Of Warrants Granted", "terseLabel": "Number of warrants granted" } } }, "localname": "NumberOfWarrantsGranted", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "sharesItemType" }, "nept_NutraceuticalProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nutraceutical products.", "label": "Nutraceutical Products [Member]", "terseLabel": "Nutraceutical Products" } } }, "localname": "NutraceuticalProductsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "nept_OperatingCashInflowPaymentsForSubleaseClassifiedAsOperatingLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating cash inflow payments for sublease classified as operating lease.", "label": "Operating Cash Inflow Payments For Sublease Classified As Operating Lease", "terseLabel": "Operating cash inflow payments for sublease classified as operating lease" } } }, "localname": "OperatingCashInflowPaymentsForSubleaseClassifiedAsOperatingLease", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureLeasesSummaryOfMovementsInCashAndNoncashFlowsFromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "nept_OperatingLeaseAnnualPaymentsEndAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease annual payments end amount.", "label": "Operating Lease Annual Payments End Amount", "terseLabel": "Annual payments end amount" } } }, "localname": "OperatingLeaseAnnualPaymentsEndAmount", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_OperatingLeaseAnnualPaymentsStartAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease annual payments start amount", "label": "Operating Lease Annual Payments Start Amount", "terseLabel": "Annual payments start amount" } } }, "localname": "OperatingLeaseAnnualPaymentsStartAmount", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_OperatingLeasesFromBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating leases from business combination.", "label": "Operating leases from business combination" } } }, "localname": "OperatingLeasesFromBusinessCombination", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureLeasesSummaryOfMovementsInCashAndNoncashFlowsFromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "nept_OperatingLossCarryForwardsWithoutLimitations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating loss carry forwards without limitations.", "label": "Operating Loss Carry forwards Without Limitations", "terseLabel": "Tax losses carried forward" } } }, "localname": "OperatingLossCarryForwardsWithoutLimitations", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_OptionsToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options to purchase common stock.", "label": "Options To Purchase Common Stock", "terseLabel": "Options to purchase common stock" } } }, "localname": "OptionsToPurchaseCommonStock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Countries [Member]", "label": "Other Countries [Member]", "terseLabel": "Other Countries" } } }, "localname": "OtherCountriesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails" ], "xbrltype": "domainItemType" }, "nept_OtherDeductibleTemporaryDifferencesWithoutTimeLimitation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other deductible temporary differences, without time limitation.", "label": "Other Deductible Temporary Differences Without Time Limitation", "terseLabel": "Other deductible temporary differences, without time limitation" } } }, "localname": "OtherDeductibleTemporaryDifferencesWithoutTimeLimitation", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "monetaryItemType" }, "nept_OtherProvisionsForOtherLegalObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other provisions for other legal obligations.", "label": "Other Provisions For Other Legal Obligations", "terseLabel": "Other provisions for other legal obligations" } } }, "localname": "OtherProvisionsForOtherLegalObligations", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_PMGSLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PMGSL.", "label": "P M G S L [Member]", "terseLabel": "PMGSL" } } }, "localname": "PMGSLMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_PayablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paybles.", "label": "Payables [Abstract]" } } }, "localname": "PayablesAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_PaymentForInterestPaid": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for interest paid.", "label": "Payment For Interest Paid", "negatedLabel": "Interest paid" } } }, "localname": "PaymentForInterestPaid", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_PaymentOfLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of lease liabilities.", "label": "Payment Of Lease Liabilities", "negatedLabel": "Payment of lease liabilities" } } }, "localname": "PaymentOfLeaseLiabilities", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_PaymentsRelatedToLitigationProvision": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments related to litigation provision.", "label": "Payments Related To Litigation Provision", "terseLabel": "Payments related to litigation provision" } } }, "localname": "PaymentsRelatedToLitigationProvision", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_PaymentsRelatedToWithholdingTaxesPaidToSettlementOfNonTreasuryRSUs": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments related to withholding taxes paid to settlement of non-treasury RSUs.", "label": "Payments Related To Withholding Taxes Paid To Settlement Of Non Treasury R S Us", "negatedLabel": "Withholding taxes paid pursuant to the settlement of non-treasury RSUs" } } }, "localname": "PaymentsRelatedToWithholdingTaxesPaidToSettlementOfNonTreasuryRSUs", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_PercentageOfEntityRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of entity revenue.", "label": "Percentage Of Entity Revenue", "terseLabel": "Percentage of net sales" } } }, "localname": "PercentageOfEntityRevenue", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_PercentageOfRoyaltiesPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of royalties payable.", "label": "Percentage Of Royalties Payable", "terseLabel": "Percentage of royalties payable" } } }, "localname": "PercentageOfRoyaltiesPayable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_PercentageOfTradeReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of trade receivables.", "label": "Percentage of trade receivables", "terseLabel": "Percentage of trade receivables" } } }, "localname": "PercentageOfTradeReceivables", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "nept_PermanentDifferenceOnImpairmentOnGoodwill": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Permanent difference on impairment on goodwill.", "label": "Permanent Difference On Impairment On Goodwill", "terseLabel": "Permanent difference on impairment on goodwill" } } }, "localname": "PermanentDifferenceOnImpairmentOnGoodwill", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nept_PostConsolidationSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post consolidation shares.", "label": "Post-Consolidation Shares [Member]", "terseLabel": "Post-Consolidation Shares" } } }, "localname": "PostConsolidationSharesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_PreConsolidationSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre Consolidation Shares.", "label": "Pre Consolidation Shares [Member]", "terseLabel": "Pre-Consolidation Shares" } } }, "localname": "PreConsolidationSharesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_PrefundWarrantDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prefund warrant description.", "label": "Prefund Warrant Description", "terseLabel": "Prefund warrant description" } } }, "localname": "PrefundWarrantDescription", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_PrefundedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prefunded warrants.", "label": "Prefunded Warrants [Member]", "terseLabel": "Prefunded Warrants" } } }, "localname": "PrefundedWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_PremiumDiscountOnWarrantsIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Premium (discount) on warrants issued.", "label": "Premium Discount On Warrants Issued", "terseLabel": "Discount on warrants issued during the year", "verboseLabel": "Premium (discount) on warrants issued during the year" } } }, "localname": "PremiumDiscountOnWarrantsIssued", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_PrepaidRoyaltyIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid royalty income.", "label": "Prepaid Royalty Income [Member]", "terseLabel": "Prepaid Royalty Income" } } }, "localname": "PrepaidRoyaltyIncomeMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "nept_ProceedsFromExerciseOfOptionsAndPreFundedWarrants": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from exercise of options and pre-funded warrants.", "label": "Proceeds from exercise of options and pre-funded warrants", "terseLabel": "Proceeds from exercise of options and pre-funded warrants" } } }, "localname": "ProceedsFromExerciseOfOptionsAndPreFundedWarrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_ProcessingServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Processing services.", "label": "Processing Services [Member]", "terseLabel": "Processing Services" } } }, "localname": "ProcessingServicesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "nept_ProductionFacilityLandAndBuildingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Production facility land and building.", "label": "Production facility land and building [Member]", "terseLabel": "Production Facility Land and Building" } } }, "localname": "ProductionFacilityLandAndBuildingMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_ProvincialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Provincial.", "label": "Provincial [Member]", "terseLabel": "Provincial" } } }, "localname": "ProvincialMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_ProvisionForLitigation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Provision for litigation.", "label": "Provision For Litigation", "terseLabel": "Provision for litigation" } } }, "localname": "ProvisionForLitigation", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ProvisionsCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Provisions current.", "label": "Provisions Current", "terseLabel": "Provisions" } } }, "localname": "ProvisionsCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_PurchaseCommitments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase commitments.", "label": "Purchase Commitments", "terseLabel": "Purchase commitments" } } }, "localname": "PurchaseCommitments", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_RealizedAndUnrealizedCapitalLossesCarryForwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Realized and unrealized capital losses carry forwards", "label": "Realized and unrealized capital losses carry forwards" } } }, "localname": "RealizedAndUnrealizedCapitalLossesCarryForwards", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_RecoveryOfStockBasedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recovery of stock-based compensation.", "label": "Recovery of Stock-based Compensation", "negatedLabel": "Recovery of stock-based compensation", "terseLabel": "Recovery of stock-based compensation" } } }, "localname": "RecoveryOfStockBasedCompensation", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_RegisteredDirectOfferingPricedAtTheMarketAndConcurrentPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Registered direct offering priced at-the-market and concurrent private placement.", "label": "Registered Direct Offering Priced At The Market And Concurrent Private Placement [Member]", "terseLabel": "Registered Direct Offering Priced At-the-market and Concurrent Private Placement" } } }, "localname": "RegisteredDirectOfferingPricedAtTheMarketAndConcurrentPrivatePlacementMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_RemainingAmountOfMinimumRoyalties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Remaining amount of minimum royalties.", "label": "Remaining Amount Of Minimum Royalties", "terseLabel": "Remaining amount of minimum royalties" } } }, "localname": "RemainingAmountOfMinimumRoyalties", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_RemainingContractsCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining contracts commitment amount.", "label": "Remaining Contracts Commitment Amount", "terseLabel": "Remaining contracts commitment amount" } } }, "localname": "RemainingContractsCommitmentAmount", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ReportingEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting entity.", "label": "Reporting Entity [Abstract]" } } }, "localname": "ReportingEntityAbstract", "nsuri": "http://www.neptunewellness.com/20220630", "xbrltype": "stringItemType" }, "nept_ReportingEntityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting entity.", "label": "Reporting Entity [Line Items]", "terseLabel": "Reporting Entity [Line Items]" } } }, "localname": "ReportingEntityLineItems", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_ReportingEntityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting Entity.", "label": "Reporting Entity [Table]", "terseLabel": "Reporting Entity [Table]" } } }, "localname": "ReportingEntityTable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_ReportingEntityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reporting entity.", "label": "Reporting Entity [Text Block]", "terseLabel": "Reporting entity" } } }, "localname": "ReportingEntityTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntity" ], "xbrltype": "textBlockItemType" }, "nept_ResearchAndDevelopmentExpensesWithoutTimeLimitation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expenses, without time limitation.", "label": "Research And Development Expenses Without Time Limitation", "terseLabel": "Research and development expenses, without time limitation" } } }, "localname": "ResearchAndDevelopmentExpensesWithoutTimeLimitation", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "monetaryItemType" }, "nept_ResearchAndDevelopmentInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research and development investment.", "label": "Research And Development Investment [Member]", "terseLabel": "Research and Development Investment" } } }, "localname": "ResearchAndDevelopmentInvestmentMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_ResidualAmountAllocated": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Residual amount allocated.", "label": "Residual Amount Allocated", "terseLabel": "Residual amount allocated" } } }, "localname": "ResidualAmountAllocated", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_RevaluationOfDerivatives": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Revaluation of derivatives.", "label": "Revaluation Of Derivatives", "terseLabel": "Revaluation of derivatives" } } }, "localname": "RevaluationOfDerivatives", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_RevaluationOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Revaluation of warrants.", "label": "Revaluation Of Warrants", "terseLabel": "Revaluation" } } }, "localname": "RevaluationOfWarrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_RightOfUseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right-of-use assets.", "label": "Right Of Use Assets [Member]", "terseLabel": "Right-of-use Assets" } } }, "localname": "RightOfUseAssetsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "nept_RoyaltyRevenues": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Royalty revenues.", "label": "Royalty Revenues", "terseLabel": "Royalty revenues" } } }, "localname": "RoyaltyRevenues", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_SalesTaxesReceivableCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": 1.0, "parentTag": "nept_TradeAndOtherReceivablesCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sales taxes receivable current.", "label": "Sales Taxes Receivable Current", "terseLabel": "Sales taxes receivable" } } }, "localname": "SalesTaxesReceivableCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "nept_ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in value of liability related to warrants.", "label": "Schedule Of Changes In Value Of Liability Related To Warrants Table [Text Block]", "terseLabel": "Summary of Changes in Value of Liability Related to Warrants" } } }, "localname": "ScheduleOfChangesInValueOfLiabilityRelatedToWarrantsTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfFairValueOfDerivativeWarrantLiabilitiesMeasurementInputsAndValuationTechniquesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of derivative warrant liabilities measurement inputs and valuation techniques.", "label": "Schedule Of Fair Value Of Derivative Warrant Liabilities Measurement Inputs And Valuation Techniques Table [Text Block]", "terseLabel": "Summary of Fair Value of Derivative Warrant Liabilities Estimated Using Black-Scholes Option Pricing Model" } } }, "localname": "ScheduleOfFairValueOfDerivativeWarrantLiabilitiesMeasurementInputsAndValuationTechniquesTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfFinanceCostsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finance costs.", "label": "Schedule Of Finance Costs Table [Text Block]", "terseLabel": "Summary of Finance Costs" } } }, "localname": "ScheduleOfFinanceCostsTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfFinanceIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finance income.", "label": "Schedule Of Finance Income Table [Text Block]", "terseLabel": "Summary of Finance Income" } } }, "localname": "ScheduleOfFinanceIncomeTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfOutstandingWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of outstanding warrants.", "label": "Schedule Of Outstanding Warrants Table [Text Block]", "terseLabel": "Summary of Outstanding Warrants" } } }, "localname": "ScheduleOfOutstandingWarrantsTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfRecognizedDeferredTaxAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of recognized deferred tax assets and liabilities.", "label": "Schedule Of Recognized Deferred Tax Assets And Liabilities [Line Items]", "terseLabel": "Schedule Of Recognized Deferred Tax Assets And Liabilities [Line Items]" } } }, "localname": "ScheduleOfRecognizedDeferredTaxAssetsAndLiabilitiesLineItems", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "nept_ScheduleOfRecognizedDeferredTaxAssetsAndLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of recognized deferred tax assets and liabilities.", "label": "Schedule Of Recognized Deferred Tax Assets And Liabilities [Table]", "terseLabel": "Schedule Of Recognized Deferred Tax Assets And Liabilities [Table]" } } }, "localname": "ScheduleOfRecognizedDeferredTaxAssetsAndLiabilitiesTable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "nept_ScheduleOfReconciliationOfChangesInFairValueOfWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of reconciliation of changes in fair value of warrants.", "label": "Schedule Of Reconciliation Of Changes In Fair Value Of Warrants Table [Text Block]", "terseLabel": "Summary of Reconciliation of Changes in Fair Value of Warrants" } } }, "localname": "ScheduleOfReconciliationOfChangesInFairValueOfWarrantsTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsTables" ], "xbrltype": "textBlockItemType" }, "nept_ScheduleOfShareBasedCompensationDeferredStockUnitsAwardActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of share based compensation deferred stock units award activity.", "label": "Schedule Of Share Based Compensation Deferred Stock Units Award Activity Table [Text Block]", "terseLabel": "Summary of Number and Weighted Average Share Prices of DSUs" } } }, "localname": "ScheduleOfShareBasedCompensationDeferredStockUnitsAwardActivityTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "nept_SeriesAWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A warrants.", "label": "Series A Warrants [Member]", "terseLabel": "Series A Warrants" } } }, "localname": "SeriesAWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_SeriesBWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B warrants.", "label": "Series B Warrants [Member]", "terseLabel": "Series B Warrants" } } }, "localname": "SeriesBWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_SeriesCWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series c warrants.", "label": "Series C Warrants [Member]", "terseLabel": "Series C Warrants" } } }, "localname": "SeriesCWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_SeriesDWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D warrants.", "label": "Series D Warrants [Member]", "terseLabel": "Series D warrants" } } }, "localname": "SeriesDWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_ShareBasedCompensationAccruedLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation accrued liability.", "label": "Share Based Compensation Accrued Liability", "terseLabel": "Accrued liability" } } }, "localname": "ShareBasedCompensationAccruedLiability", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercisable in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period", "terseLabel": "Shares exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercisable, weighted average grant date fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average share price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails" ], "xbrltype": "perShareItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedForPastServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, granted for past services.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted For Past Services", "terseLabel": "Number of other equity instruments exercised or vested in share based payment arrangement granted for past services" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedForPastServices", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedThroughIssuanceOfCommonSharesWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, released through issuance of common shares, weighted average grant date fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Through Issuance Of Common Shares Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average share price, Released through the issuance of common shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedThroughIssuanceOfCommonSharesWeightedAverageGrantDateFairValue", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "perShareItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesReleasedThroughIssuanceOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares released through issuance of common shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Shares Released Through Issuance Of Common Shares", "negatedLabel": "Shares outstanding, Released through the issuance of common shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesReleasedThroughIssuanceOfCommonShares", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesWithheldAsPaymentOfWithholdingTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options shares withheld as payment of withholding taxes.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Shares Withheld As Payment Of Withholding Taxes", "negatedLabel": "Shares outstanding, Withheld as payment of withholding taxes" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesWithheldAsPaymentOfWithholdingTaxes", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAfterCompletionOfServiceToBeRendered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested after completion of service to be rendered.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested After Completion Of Service To Be Rendered", "terseLabel": "Number of other equity instruments exercised or vested in share based payment arrangement after completion of service" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAfterCompletionOfServiceToBeRendered", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedUponServicesToBeRender12MonthsFromDateOfGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested upon services to be render 12 months from date of grant.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Upon Services To Be Render12 Months From Date Of Grant", "terseLabel": "Number of other equity instruments exercised or vested in share based payment arrangement upon services to be render 12 months from date of grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedUponServicesToBeRender12MonthsFromDateOfGrant", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "nept_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageSharesWithheldAsPaymentOfWithholdingTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options weighted average shares withheld as payment of withholding taxes.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Shares Withheld As Payment Of Withholding Taxes", "terseLabel": "Weighted average share price, Withheld as payment of withholding taxes" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageSharesWithheldAsPaymentOfWithholdingTaxes", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "perShareItemType" }, "nept_ShareBasedCompensationCashEntitled": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation cash entitled.", "label": "Share Based Compensation Cash Entitled", "terseLabel": "Cash entitled" } } }, "localname": "ShareBasedCompensationCashEntitled", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareBasedCompensationGainOnRevaluationOfLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation, gain on revaluation of liability.", "label": "Share Based Compensation, Gain on Revaluation of Liability", "terseLabel": "Gain on revaluation of liability" } } }, "localname": "ShareBasedCompensationGainOnRevaluationOfLiability", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareBasedCompensationMaximumInsuranceCoverage": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation maximum insurance coverage.", "label": "Share Based Compensation Maximum Insurance Coverage", "terseLabel": "Maximum insurance coverage" } } }, "localname": "ShareBasedCompensationMaximumInsuranceCoverage", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareBasedCompensationSettlementValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation, settlement value.", "label": "Share Based Compensation, Settlement Value", "terseLabel": "Share based compensation, settlement value" } } }, "localname": "ShareBasedCompensationSettlementValue", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareBasedCompensationValueOfRSUsEntitledToGrant": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation value of RSUs entitled to grant.", "label": "Share Based Compensation Value Of R S Us Entitled To Grant", "terseLabel": "Value of RSUs entitled to grant" } } }, "localname": "ShareBasedCompensationValueOfRSUsEntitledToGrant", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_ShareCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share capital.", "label": "Share Capital [Member]", "terseLabel": "Share Capital" } } }, "localname": "ShareCapitalMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "nept_SignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Line Items]", "terseLabel": "Significant Accounting Policies [Line Items]" } } }, "localname": "SignificantAccountingPoliciesLineItems", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Table]", "terseLabel": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_SproutCallOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sprout call option.", "label": "Sprout Call Option [Member]", "terseLabel": "Sprout Call Option" } } }, "localname": "SproutCallOptionMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_SproutFoodsIncAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sprout Foods Inc. acquisition.", "label": "Sprout Foods Inc Acquisition [Member]", "terseLabel": "Sprout Foods, Inc Acquisition", "verboseLabel": "Sprout" } } }, "localname": "SproutFoodsIncAcquisitionMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_SproutFoodsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sprout Foods, Inc.", "label": "Sprout Foods Inc [Member]", "terseLabel": "Sprout Foods, Inc." } } }, "localname": "SproutFoodsIncMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "nept_SproutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sprout.", "label": "Sprout [Member]", "terseLabel": "Sprout" } } }, "localname": "SproutMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails" ], "xbrltype": "domainItemType" }, "nept_SubsequentEvent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subsequent event.", "label": "Subsequent Event", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEvent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_SubsidiesDeductedFromCostOfSales": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subsidies deducted from cost of sales.", "label": "Subsidies Deducted From Cost Of Sales", "terseLabel": "Subsidies deducted from cost of sales" } } }, "localname": "SubsidiesDeductedFromCostOfSales", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "nept_SubsidiesDeductedFromSellingGeneralAndAdministrativeExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subsidies deducted from selling, general and administrative expenses.", "label": "Subsidies Deducted From Selling General And Administrative Expenses", "terseLabel": "Subsidies deducted from selling, general and administrative expenses" } } }, "localname": "SubsidiesDeductedFromSellingGeneralAndAdministrativeExpenses", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "nept_SugarLeafMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SugarLeaf.", "label": "Sugar Leaf [Member]", "terseLabel": "SugarLeaf" } } }, "localname": "SugarLeafMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial information of non-controlling interest.", "label": "Summarized Financial Information Of Noncontrolling Interest Table [Text Block]", "terseLabel": "Summarized Financial Information of Non-controlling Interest" } } }, "localname": "SummarizedFinancialInformationOfNoncontrollingInterestTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestTables" ], "xbrltype": "textBlockItemType" }, "nept_SummaryOfCashFlowInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of cash flow information.", "label": "Summary Of Cash Flow Information Table [Text Block]", "terseLabel": "Summary of Movements in Cash and Non-cash Flows from Operating Leases" } } }, "localname": "SummaryOfCashFlowInformationTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "nept_SummaryOfRemainingLeaseTermAndDiscountRatesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of remaining lease term and discount rates.", "label": "Summary Of Remaining Lease Term And Discount Rates Table [Text Block]", "terseLabel": "Summary of Weighted-average Remaining Lease Term, and Weighted-average Discount Rate" } } }, "localname": "SummaryOfRemainingLeaseTermAndDiscountRatesTableTextBlock", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "nept_TaxCreditsReceivable": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": 3.0, "parentTag": "nept_TradeAndOtherReceivablesCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax credits receivable.", "label": "Tax Credits Receivable", "terseLabel": "Tax credits receivable" } } }, "localname": "TaxCreditsReceivable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "nept_TaxCreditsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax credits receivable.", "label": "Tax Credits Receivable [Member]", "terseLabel": "Tax Credits Receivable" } } }, "localname": "TaxCreditsReceivableMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "nept_TaxExpenseIncomeAtApplicableTaxRate": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 0.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax expense income at applicable tax rate.", "label": "Tax Expense Income At Applicable Tax Rate", "terseLabel": "Income tax" } } }, "localname": "TaxExpenseIncomeAtApplicableTaxRate", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nept_TaxLossesCarriedForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax losses carried forward.", "label": "Tax Losses Carried Forward [Member]", "terseLabel": "Tax Losses Carried Forward" } } }, "localname": "TaxLossesCarriedForwardMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2023.", "label": "Tax Year2023 [Member]", "terseLabel": "2023" } } }, "localname": "TaxYear2023Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2024.", "label": "Tax Year2024 [Member]", "terseLabel": "2024" } } }, "localname": "TaxYear2024Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2025.", "label": "Tax Year2025 [Member]", "terseLabel": "2025" } } }, "localname": "TaxYear2025Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2026.", "label": "Tax Year2026 [Member]", "terseLabel": "2026" } } }, "localname": "TaxYear2026Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2027.", "label": "Tax Year2027 [Member]", "terseLabel": "2027" } } }, "localname": "TaxYear2027Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2028.", "label": "Tax Year2028 [Member]", "terseLabel": "2028" } } }, "localname": "TaxYear2028Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2029.", "label": "Tax Year2029 [Member]", "terseLabel": "2029" } } }, "localname": "TaxYear2029Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2030.", "label": "Tax Year2030 [Member]", "terseLabel": "2030" } } }, "localname": "TaxYear2030Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2031.", "label": "Tax Year2031 [Member]", "terseLabel": "2031" } } }, "localname": "TaxYear2031Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2032Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2032.", "label": "Tax Year2032 [Member]", "terseLabel": "2032" } } }, "localname": "TaxYear2032Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2033Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2033.", "label": "Tax Year2033 [Member]", "terseLabel": "2033" } } }, "localname": "TaxYear2033Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2034Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2034.", "label": "Tax Year2034 [Member]", "terseLabel": "2034" } } }, "localname": "TaxYear2034Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2035Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2035.", "label": "Tax Year2035 [Member]", "terseLabel": "2035" } } }, "localname": "TaxYear2035Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2036Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2036.", "label": "Tax Year2036 [Member]", "terseLabel": "2036" } } }, "localname": "TaxYear2036Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2037Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2037.", "label": "Tax Year2037 [Member]", "terseLabel": "2037" } } }, "localname": "TaxYear2037Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2038Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2038.", "label": "Tax Year2038 [Member]", "terseLabel": "2038" } } }, "localname": "TaxYear2038Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2039.", "label": "Tax Year2039 [Member]", "terseLabel": "2039" } } }, "localname": "TaxYear2039Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2040Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2040.", "label": "Tax Year2040 [Member]", "terseLabel": "2040" } } }, "localname": "TaxYear2040Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2041Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2041.", "label": "Tax Year2041 [Member]", "terseLabel": "2041" } } }, "localname": "TaxYear2041Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TaxYear2042Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year 2042.", "label": "Tax Year2042 [Member]", "terseLabel": "2042" } } }, "localname": "TaxYear2042Member", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "nept_TermOfAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of agreement.", "label": "Term Of Agreement", "terseLabel": "Term of agreement" } } }, "localname": "TermOfAgreement", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "nept_TermOfLicensingAndCapsulesAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of licensing and capsules agreement..", "label": "Term Of Licensing And Capsules Agreement", "terseLabel": "Term of licensing and capsules agreement" } } }, "localname": "TermOfLicensingAndCapsulesAgreement", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "nept_TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialtyIngredient": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of minimum annual volume of sales to maintain exclusivity of specialty ingredient.", "label": "Term Of Minimum Annual Volume Of Sales To Maintain Exclusivity Of Specialty Ingredient", "terseLabel": "Term of minimum annual volume of sales to maintain exclusivity of specialty ingredient" } } }, "localname": "TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialtyIngredient", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "nept_TradeAccountsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of trade accounts.", "label": "Trade Accounts Percentage", "terseLabel": "Trade receivables" } } }, "localname": "TradeAccountsPercentage", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "nept_TradeAndOtherPayablesCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade and other payables current.", "label": "Trade And Other Payables Current", "terseLabel": "Trade and other payables", "totalLabel": "Trade and other payables current" } } }, "localname": "TradeAndOtherPayablesCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_TradeAndOtherReceivablesCurrent": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Trade and other receivables current.", "label": "Trade And Other Receivables Current", "terseLabel": "Trade and other receivables", "totalLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivablesCurrent", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_TradeAndOtherReceivablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade and other receivables.", "label": "Trade And Other Receivables [Member]", "terseLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivablesMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "nept_TradeReceivablesExpectedCreditLoss": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade receivables expected credit loss.", "label": "Trade Receivables Expected Credit Loss", "negatedLabel": "Less expected credit loss" } } }, "localname": "TradeReceivablesExpectedCreditLoss", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "nept_TranslationEffectOnWarrantLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Translation effect on warrant liabilities.", "label": "Translation Effect On Warrant Liabilities", "terseLabel": "Translation effect" } } }, "localname": "TranslationEffectOnWarrantLiabilities", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_TwoThousandAndTwentyOneWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty one warrants.", "label": "Two Thousand And Twenty One Warrants [Member]", "terseLabel": "2021 Warrants" } } }, "localname": "TwoThousandAndTwentyOneWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_TwoThousandAndTwentyWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty warrants", "label": "Two Thousand And Twenty Warrants [Member]", "terseLabel": "2020 Warrants" } } }, "localname": "TwoThousandAndTwentyWarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "nept_UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unused tax credits for which no deferred tax asset recognised.", "label": "Unused Tax Credits For Which No Deferred Tax Asset Recognised", "terseLabel": "Unused tax credits for which no deferred tax asset recognised" } } }, "localname": "UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "monetaryItemType" }, "nept_ValueOfWarrantsRecognizedAsExpenseDuringPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of warrants recognized as expense during period.", "label": "Value Of Warrants Recognized As Expense During Period", "terseLabel": "Value of warrants recognized as expense during period" } } }, "localname": "ValueOfWarrantsRecognizedAsExpenseDuringPeriod", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "nept_WageAndRentSubsidies": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Wage and rent subsidies.", "label": "Wage And Rent Subsidies", "terseLabel": "Wage and rent subsidies" } } }, "localname": "WageAndRentSubsidies", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_WageAndRentSubsidiesReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Wage and rent subsidies receivable.", "label": "Wage And Rent Subsidies Receivable", "terseLabel": "Wage and rent subsidies receivable" } } }, "localname": "WageAndRentSubsidiesReceivable", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantExercisableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercisable term.", "label": "Warrant Exercisable Term", "verboseLabel": "Warrant exercisable term" } } }, "localname": "WarrantExercisableTerm", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "nept_WarrantExercisedExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercised exercise price.", "label": "Warrant Exercised Exercise Price", "terseLabel": "Exercised, Weighted average exercise price" } } }, "localname": "WarrantExercisedExercisePrice", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails" ], "xbrltype": "perShareItemType" }, "nept_WarrantIssuedExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant issued exercise price.", "label": "Warrant Issued Exercise Price", "terseLabel": "Issued, Weighted average exercise price" } } }, "localname": "WarrantIssuedExercisePrice", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails" ], "xbrltype": "perShareItemType" }, "nept_Warrants": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants.", "label": "Warrants", "terseLabel": "Warrants" } } }, "localname": "Warrants", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsAMIFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants AMI financing.", "label": "Warrants A M I Financing [Member]", "terseLabel": "Warrants AMI" } } }, "localname": "WarrantsAMIFinancingMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "domainItemType" }, "nept_WarrantsAndRightsOutstandingIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance date of outstanding warrants and rights.", "label": "Warrants And Rights Outstanding Issuance Date", "terseLabel": "Date of issuance" } } }, "localname": "WarrantsAndRightsOutstandingIssuanceDate", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails" ], "xbrltype": "dateItemType" }, "nept_WarrantsCancelled": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants cancelled.", "label": "Warrants Cancelled", "terseLabel": "Warrants cancelled during the year" } } }, "localname": "WarrantsCancelled", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercise price.", "label": "Warrants Exercise Price", "terseLabel": "Warrants exercise price" } } }, "localname": "WarrantsExercisePrice", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "perShareItemType" }, "nept_WarrantsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants exercised.", "label": "Warrants Exercised", "terseLabel": "Warrants exercised during the period" } } }, "localname": "WarrantsExercised", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsExpirationPeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants expiration period one.", "label": "Warrants Expiration Period One [Member]", "terseLabel": "Warrants Expiring on October 3, 2024" } } }, "localname": "WarrantsExpirationPeriodOneMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "domainItemType" }, "nept_WarrantsExpirationPeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants expiration period two.", "label": "Warrants Expiration Period Two [Member]", "terseLabel": "Warrants Expiring on February 5, 2025" } } }, "localname": "WarrantsExpirationPeriodTwoMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "domainItemType" }, "nept_WarrantsExpired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants expired.", "label": "Warrants Expired", "terseLabel": "Warrants expired during the year" } } }, "localname": "WarrantsExpired", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsIFFFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants IFF financing.", "label": "Warrants I F F Financing [Member]", "terseLabel": "Warrants IFF" } } }, "localname": "WarrantsIFFFinancingMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "domainItemType" }, "nept_WarrantsInExchangeOfServicesRenderedByNonEmployees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants in exchange of services rendered by non-employees.", "label": "Warrants In Exchange Of Services Rendered By Non Employees", "negatedLabel": "Warrants in exchange of services rendered by non-employees" } } }, "localname": "WarrantsInExchangeOfServicesRenderedByNonEmployees", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails": { "order": 3.0, "parentTag": "nept_FinanceCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants issuance costs.", "label": "Warrants Issuance Costs", "negatedLabel": "Warrants issuance costs", "terseLabel": "Warrants issuance costs" } } }, "localname": "WarrantsIssuanceCosts", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants issued.", "label": "Warrants Issued", "terseLabel": "Warrants issued during the period", "verboseLabel": "Warrant issued" } } }, "localname": "WarrantsIssued", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "nept_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants.", "label": "Warrants [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantsMember", "nsuri": "http://www.neptunewellness.com/20220630", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "label": "Board Of Directors Chairman [Member]", "terseLabel": "Board of Directors" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "CEO" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r71", "r73", "r136", "r137", "r305", "r344" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r206", "r370", "r374", "r682" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r282", "r284", "r285", "r286", "r304", "r343", "r390", "r392", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r679", "r683", "r708", "r709" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r282", "r284", "r285", "r286", "r304", "r343", "r390", "r392", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r679", "r683", "r708", "r709" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r206", "r370", "r374", "r682" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r200", "r284", "r285", "r370", "r372", "r618", "r678", "r680" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r200", "r284", "r285", "r370", "r372", "r618", "r678", "r680" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r274", "r282", "r284", "r285", "r286", "r304", "r343", "r379", "r390", "r392", "r428", "r429", "r430", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r679", "r683", "r708", "r709" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r274", "r282", "r284", "r285", "r286", "r304", "r343", "r379", "r390", "r392", "r428", "r429", "r430", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r679", "r683", "r708", "r709" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r72", "r73", "r136", "r137", "r305", "r344" ], "lang": { "en-us": { "role": { "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r201", "r202", "r370", "r373", "r681", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r201", "r202", "r370", "r373", "r681", "r693", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707" ], "lang": { "en-us": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r208", "r596" ], "lang": { "en-us": { "role": { "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "stpr_CA-QC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "QUEBEC", "terseLabel": "Quebec" } } }, "localname": "CA-QC", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "stpr_NC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NORTH CAROLINA", "terseLabel": "North Carolina" } } }, "localname": "NC", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Accounts Notes Loans And Financing Receivable By Receivable Type [Axis]", "terseLabel": "Receivable Type" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable And Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Trade and other payables" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r23", "r56" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": { "order": 0.0, "parentTag": "nept_TradeAndOtherPayablesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Trade Current", "terseLabel": "Trade payables" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable Allowance For Credit Loss Table [Text Block]", "terseLabel": "Summary of Movement in Expected Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r19", "r38", "r209", "r210" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails": { "order": 0.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Gross Current", "terseLabel": "Trade receivables, gross" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r209", "r210" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails": { "order": 0.0, "parentTag": "nept_TradeAndOtherReceivablesCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Trade receivables", "totalLabel": "Trade Receivables" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxes": { "auth_ref": [ "r31", "r34", "r453", "r636", "r660" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.", "label": "Accrued Income Taxes", "terseLabel": "Withholding taxes to paid", "totalLabel": "Accrued Income Taxes, Total" } } }, "localname": "AccruedIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r41", "r77", "r79", "r80", "r662", "r688", "r689" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r76", "r80", "r87", "r88", "r89", "r140", "r141", "r142", "r519", "r590", "r684", "r685" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r39" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r140", "r141", "r142", "r439", "r440", "r441", "r535" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r119", "r256" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Adjustment For Amortization", "terseLabel": "Accelerated amortization of property, plant and equipment", "totalLabel": "Amortization, Total" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r394", "r442", "r443" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Share-based payment", "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Stock-based compensation recognized" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r119", "r250", "r256" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization of intangible assets", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r119", "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "totalLabel": "Asset Impairment Charges, Total", "verboseLabel": "Impairment loss" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r30", "r132", "r184", "r189", "r196", "r218", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r514", "r521", "r549", "r600", "r602", "r635", "r659" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r21", "r55", "r132", "r218", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r514", "r521", "r549", "r600", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "terseLabel": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [ "r259", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.", "label": "Assets Held-for-sale, Not Part of Disposal Group, Current", "terseLabel": "Assets held for sale", "totalLabel": "Assets Held-for-sale, Not Part of Disposal Group, Current, Total" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r132", "r218", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r514", "r521", "r549", "r600" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets Noncurrent", "terseLabel": "Non-current assets", "totalLabel": "Assets, Noncurrent, Total" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r10", "r12", "r15", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "totalLabel": "Assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "New Building Lease" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r389", "r391", "r499" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r389", "r391", "r491", "r492", "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition Cost Of Acquired Entity Transaction Costs", "terseLabel": "Acquisition-related costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r480", "r481", "r482" ], "lang": { "en-us": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.", "label": "Business Acquisition Effective Date Of Acquisition1", "terseLabel": "Business acquisition, date of acquisition" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition Equity Interest Issued Or Issuable Value Assigned", "terseLabel": "Business acquisition, common shares value", "verboseLabel": "Business acquisition, notes guaranteed" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued", "terseLabel": "Shares issued as consideration for acquisition", "verboseLabel": "Business acquisition, issuance of shares, value" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition Percentage Of Voting Interests Acquired", "terseLabel": "Equity interest acquired", "verboseLabel": "Business acquisition, percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition Pro Forma Information [Text Block]", "terseLabel": "Schedule of Unaudited Pro forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r489", "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisitions Pro Forma Net Income Loss", "terseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfUnauditedProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r489", "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisitions Pro Forma Revenue", "terseLabel": "Total revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfUnauditedProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible": { "auth_ref": [ "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the best estimate at the acquisition date of the contractual cash flows not expected to be collected, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.", "label": "Business Combination Acquired Receivables Estimated Uncollectible", "terseLabel": "Trade accounts receivable, estimated uncollectible" } } }, "localname": "BusinessCombinationAcquiredReceivablesEstimatedUncollectible", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount": { "auth_ref": [ "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.", "label": "Business Combination Acquired Receivables Gross Contractual Amount", "terseLabel": "Trade accounts receivable, gross" } } }, "localname": "BusinessCombinationAcquiredReceivablesGrossContractualAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value", "negatedLabel": "Non-controlling interest measured at fair value (49.9%)" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r502", "r503", "r504" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination Consideration Transferred1", "totalLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r502", "r503" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination Consideration Transferred Equity Interests Issued And Issuable", "terseLabel": "Common shares issued, at fair value" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r501", "r502", "r503", "r506" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination Consideration Transferred Liabilities Incurred", "terseLabel": "Guaranteeing of note issued" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r500", "r508" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business combination" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r488" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual", "negatedLabel": "Net loss of acquiree since acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r488" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual", "terseLabel": "Revenue of acquiree since acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets", "totalLabel": "Assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation", "terseLabel": "Lease liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Trade receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable", "terseLabel": "Trade and other payables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets", "terseLabel": "Tradenames" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r493", "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities", "totalLabel": "Liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r493", "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net", "totalLabel": "Total identifiable net assets at fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt", "terseLabel": "Promissory note" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r493", "r496" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment", "terseLabel": "Property and equipment", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment, Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "auth_ref": [ "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.", "label": "Business Combination Step Acquisition Equity Interest In Acquiree Fair Value1", "terseLabel": "Value of asset" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": { "auth_ref": [ "r485" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net", "terseLabel": "(Loss) gain on re-measurement of revaluation of derivatives", "totalLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net, Total" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeValuationTechniques": { "auth_ref": [ "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, description of the valuation technique(s) used to measure the acquisition date fair value of the equity interest in the acquiree held by the acquirer immediately before the business combination and information that enables users of the acquirer's financial statements to assess the inputs used to develop the fair value measurement of the equity interest in the acquiree held by the acquirer immediately before the business combination.", "label": "Business Combination Step Acquisition Equity Interest In Acquiree Valuation Techniques", "terseLabel": "Market price description" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeValuationTechniques", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r16", "r139", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description And Basis Of Presentation [Text Block]", "terseLabel": "Basis of preparation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparation1" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r28", "r602", "r691", "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash on hand" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash And Cash Equivalents [Abstract]", "terseLabel": "Cash and cash equivalents is comprised of:" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r17", "r28", "r121" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r115", "r121", "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash and cash equivalents as at June 30, 2022 and 2021", "periodStartLabel": "Cash and cash equivalents, beginning of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r115", "r555" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow Supplemental Disclosures [Text Block]", "terseLabel": "Supplemental Cash Flow Disclosure" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosure" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r35", "r36", "r37", "r129", "r132", "r155", "r156", "r157", "r159", "r161", "r169", "r170", "r171", "r218", "r290", "r294", "r295", "r296", "r299", "r300", "r341", "r342", "r346", "r350", "r357", "r549", "r716" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r365", "r396" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class Of Warrant Or Right [Axis]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class Of Warrant Or Right [Domain]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "periodEndLabel": "Warrants outstanding, Weighted average exercise price", "periodStartLabel": "Warrants outstanding, Weighted average exercise price", "terseLabel": "Exercise price of warrants", "verboseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Warrant Or Right [Line Items]", "terseLabel": "Class Of Warrant Or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right", "terseLabel": "Number of shares exercisable for common share" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Class of warrant or right, number of securities called by warrants or rights", "verboseLabel": "Warrants to purchase common shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Outstanding", "periodEndLabel": "Number of warrants outstanding, ending balance", "periodStartLabel": "Number of warrants outstanding, beginning balance", "terseLabel": "Number of warrants outstanding", "verboseLabel": "Pre-funded warrants" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r365", "r396" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class Of Warrant Or Right [Table]", "terseLabel": "Class Of Warrant Or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Promissory Note" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r66", "r644", "r667" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r276", "r277", "r278", "r287", "r695" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r140", "r141", "r535" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock, No Par Value", "terseLabel": "Common shares par value" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common shares issued", "verboseLabel": "Number of shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r37", "r357" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock outstanding", "verboseLabel": "Common shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r37", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Share capital - without par value (7,614,434 shares issued and outstanding as of June 30, 2022; 5,560,829 shares issued and outstanding as of March 31, 2022)", "verboseLabel": "Common shares issued, value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r83", "r85", "r86", "r99", "r650", "r673" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Equity holders of the Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r83", "r85", "r98", "r512", "r513", "r525", "r649", "r672" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest", "terseLabel": "Non-controlling interest", "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total", "verboseLabel": "Comprehensive loss attributable to the subsidiary's non-controlling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r83", "r85", "r97", "r511", "r525", "r648", "r671" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest", "terseLabel": "Total comprehensive loss", "totalLabel": "Total comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest [Abstract]", "terseLabel": "Total comprehensive loss attributable to:" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r173", "r174", "r206", "r547", "r548", "r694" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r173", "r174", "r206", "r547", "r548", "r690", "r694" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r173", "r174", "r206", "r547", "r548", "r690", "r694" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r173", "r174", "r206", "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of consolidated revenue" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r173", "r174", "r206", "r547", "r548", "r694" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerDurationAxis": { "auth_ref": [ "r370", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.", "label": "Contract With Customer Duration [Axis]", "terseLabel": "Contract with Customer, Duration" } } }, "localname": "ContractWithCustomerDurationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerDurationDomain": { "auth_ref": [ "r370", "r376" ], "lang": { "en-us": { "role": { "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.", "label": "Contract With Customer Duration [Domain]", "terseLabel": "Contract with Customer, Duration" } } }, "localname": "ContractWithCustomerDurationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r367", "r368", "r371" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract With Customer Liability Current", "terseLabel": "Deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "auth_ref": [ "r122", "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Information by description of stock conversions.", "label": "Stock Conversion Description [Axis]" } } }, "localname": "ConversionOfStockByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockNameDomain": { "auth_ref": [ "r122", "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion.", "label": "Conversion of Stock, Name [Domain]" } } }, "localname": "ConversionOfStockNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r103", "r618" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "negatedTotalLabel": "Total Cost of sales", "terseLabel": "Revenue from sale of goods and services", "totalLabel": "Cost of Goods and Services Sold, Total" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r104", "r132", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r549" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost Of Revenue", "negatedLabel": "Cost of sales", "terseLabel": "Revenue realized", "totalLabel": "Cost of Revenue, Total" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of goods sold", "verboseLabel": "Cost of Sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r133", "r463", "r471", "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current", "totalLabel": "Current Income Tax Expense (Benefit), Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxRecoveryExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r172", "r206" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r128", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r318", "r325", "r326", "r328", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Loans and borrowings" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowings" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r301", "r332", "r333", "r568", "r570", "r571" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Loans and borrowings", "verboseLabel": "Secured Promissory Notes" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r62", "r330", "r568", "r570" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Loans and borrowings, interest rate", "verboseLabel": "Secured Promissory Notes, Interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt Instrument Interest Rate Terms", "terseLabel": "Loans and borrowings, interest payable description", "verboseLabel": "Secured Promissory Notes, interest payable description" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r63", "r304", "r542" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Loans and borrowings, payable date", "verboseLabel": "Maturity date of note" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r64", "r131", "r138", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r314", "r315", "r316", "r317", "r319", "r320", "r321", "r322", "r323", "r324", "r327", "r332", "r333", "r334", "r335", "r358", "r361", "r362", "r363", "r567", "r568", "r570", "r571", "r657" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": { "order": 3.0, "parentTag": "nept_TradeAndOtherPayablesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt Longterm And Shortterm Combined Amount", "terseLabel": "Short-term portion of long-term payables", "totalLabel": "Debt, Long-Term and Short-Term, Combined Amount, Total" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCurrentAndNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of deferred costs.", "label": "Deferred Costs Current And Noncurrent", "terseLabel": "Total issue costs", "totalLabel": "Deferred Costs, Total" } } }, "localname": "DeferredCostsCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r119", "r133", "r464", "r471", "r472", "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred tax (recovery) expense", "totalLabel": "Deferred Income Tax Expense (Benefit), Total", "verboseLabel": "Deferred taxes recovery" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxRecoveryExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]", "terseLabel": "Deferred Tax Asset" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r461" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Non-deductible interest" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from a gain reported for tax purposes on sale and leaseback transactions in accordance with enacted tax laws.", "label": "Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction", "terseLabel": "Financing fees not currently deductible for tax purposes" } } }, "localname": "DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Intangible assets and goodwill" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r455" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Subtotal", "totalLabel": "Subtotal" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "Research and development costs" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r457" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "terseLabel": "Net deferred tax assets", "totalLabel": "Total net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r459", "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Net operating losses (NOL) and tax credit carryforwards", "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Reserves and accruals not currently deductible for tax purposes", "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r456" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Less: valuation allowance", "verboseLabel": "Deferred tax assets, valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r448", "r457" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "negatedTotalLabel": "Total deferred tax liabilities", "terseLabel": "Deferred tax liability", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedLabel": "Intangible assets and goodwill", "terseLabel": "Intangible assets and goodwill", "totalLabel": "Deferred Tax Liabilities, Goodwill and Intangible Assets, Total" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities Other", "negatedLabel": "Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r461", "r462" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities Property Plant And Equipment", "negatedLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfNetDeferredTaxAssetLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r70", "r73", "r74", "r529", "r615" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Fair Value Of Derivative Liability", "terseLabel": "Liability related to warrants" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r104" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_CostOfGoodsAndServicesSold", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Direct Operating Costs", "negatedLabel": "Cost of sales other than loss on inventories, net of subsidies of nil (2021 - $662,495 )", "totalLabel": "Direct Operating Costs, Total" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of Revenue Derived from Sale of Goods" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r397", "r398", "r434", "r435", "r437", "r444" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Share-based Payment" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPayment" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).", "label": "Disclosure of Long-Lived Assets Held-for-sale [Table Text Block]", "terseLabel": "Summary of Assets Held for Sale" } } }, "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r2", "r3", "r10", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Trade and other receivables" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "auth_ref": [ "r2", "r3", "r10", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "terseLabel": "Trade and other payables" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": { "auth_ref": [ "r2", "r3", "r10", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current", "terseLabel": "Deferred revenues" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r2", "r3", "r10", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 6.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": { "auth_ref": [ "r2", "r3", "r10", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Inventory, Current", "terseLabel": "Inventories" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "auth_ref": [ "r2", "r3", "r10", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "auth_ref": [ "r2", "r3", "r10", "r270" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Property, plant and equipment reclassified to assets held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "auth_ref": [ "r119", "r262", "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "negatedLabel": "Loss on disposal", "terseLabel": "Loss on disposal" } } }, "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Basic and diluted loss per share attributable to:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r100", "r145", "r146", "r147", "r148", "r149", "r153", "r155", "r159", "r160", "r161", "r165", "r166", "r536", "r537", "r651", "r674" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share Basic", "terseLabel": "Total loss per share, basic", "totalLabel": "Earnings Per Share, Basic, Total" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r100", "r145", "r146", "r147", "r148", "r149", "r155", "r159", "r160", "r161", "r165", "r166", "r536", "r537", "r651", "r674" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Diluted", "terseLabel": "Total loss per share, diluted", "totalLabel": "Earnings Per Share, Diluted, Total" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r162", "r163", "r164", "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Loss per share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r555" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "terseLabel": "Foreign exchange loss on cash and cash equivalents", "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "verboseLabel": "Foreign exchange loss on cash and cash equivalents held in foreign currencies" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r134", "r450", "r474" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate", "terseLabel": "Basic combined Canadian statutory income tax rate 1" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r643", "r668" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": { "order": 2.0, "parentTag": "nept_TradeAndOtherPayablesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Employee Related Liabilities Current And Noncurrent", "terseLabel": "Employee salaries and benefits payable", "totalLabel": "Employee-related Liabilities, Total" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total", "verboseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "verboseLabel": "Unrecognized compensation cost weighted average remaining life" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Option Plan", "verboseLabel": "Stock Options Exercised" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r87", "r88", "r89", "r140", "r141", "r142", "r144", "r150", "r152", "r168", "r219", "r357", "r364", "r439", "r440", "r441", "r467", "r468", "r535", "r556", "r557", "r558", "r559", "r560", "r563", "r590", "r684", "r685", "r686" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ExciseAndSalesTaxes": { "auth_ref": [ "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.", "label": "Excise and Sales Taxes", "terseLabel": "Excise taxes" } } }, "localname": "ExciseAndSalesTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r538", "r539", "r545" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings": { "auth_ref": [ "r543" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset and liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings", "terseLabel": "Gain (loss) on re-measurement of financial assets and liabilities measured at fair value", "totalLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings, Total" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r316", "r332", "r333", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r388", "r539", "r606", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r538", "r539", "r541", "r542", "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r316", "r380", "r381", "r386", "r388", "r539", "r606" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r316", "r332", "r333", "r380", "r381", "r386", "r388", "r539", "r607" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r316", "r332", "r333", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r388", "r539", "r608" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r316", "r332", "r333", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r388", "r606", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r544", "r546" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Fair Value Measurements Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r576", "r581", "r588" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails": { "order": 2.0, "parentTag": "nept_FinanceCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease Interest Expense", "negatedLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Total", "totalLabel": "Financial Liabilities Fair Value Disclosure, Total" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) allowance for credit loss on financing receivable. Excludes net investment in lease.", "label": "Financing Receivable Allowance For Credit Loss Foreign Currency Translation", "terseLabel": "Foreign exchange loss" } } }, "localname": "FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfMovementInExpectedCreditLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r45", "r211", "r220", "r221", "r224", "r642", "r717", "r718", "r719" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable Allowance For Credit Losses", "periodEndLabel": "Balance, end of year", "periodStartLabel": "Balance, beginning of year" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfMovementInExpectedCreditLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRecovery": { "auth_ref": [ "r213", "r223", "r227" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on financing receivable from recovery.", "label": "Financing Receivable, Allowance for Credit Loss, Recovery", "negatedLabel": "Recoveries collected", "terseLabel": "Recoveries collected" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRecovery", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfMovementInExpectedCreditLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesWriteOffs": { "auth_ref": [ "r212", "r222", "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of financing receivable, charged against allowance for credit loss.", "label": "Financing Receivable Allowance For Credit Losses Write Offs", "terseLabel": "Bad debt expenses" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesWriteOffs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfMovementInExpectedCreditLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable Recorded Investment Past Due [Line Items]", "terseLabel": "Financing Receivable Recorded Investment Past Due [Line Items]" } } }, "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Financial asset equal to or greater than 90 days past due.", "label": "Financing Receivables Equal To Greater Than90 Days Past Due [Member]", "terseLabel": "Past due over 121 days" } } }, "localname": "FinancingReceivablesEqualToGreaterThan90DaysPastDueMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivablesPeriodPastDueAxis": { "auth_ref": [ "r215", "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "Information by period in which financial asset is past due or not past due.", "label": "Financing Receivables Period Past Due [Axis]", "terseLabel": "Financial Asset, Aging" } } }, "localname": "FinancingReceivablesPeriodPastDueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesPeriodPastDueDomain": { "auth_ref": [ "r215", "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats.", "label": "Financing Receivables Period Past Due [Domain]", "terseLabel": "Financial Asset, Aging" } } }, "localname": "FinancingReceivablesPeriodPastDueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r251", "r252", "r255", "r257", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r251", "r254" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite Lived Intangible Assets [Member]", "verboseLabel": "Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r550", "r551", "r552", "r554" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "terseLabel": "Foreign exchange gains (losses)", "totalLabel": "Foreign Currency Transaction Gain (Loss), before Tax, Total" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r120", "r552", "r554" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Unrealized", "negatedLabel": "Unrealized foreign exchange (gain) loss" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r528" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain Loss On Derivative Instruments Net Pretax", "terseLabel": "Gain on revaluation of derivatives", "totalLabel": "Gain (Loss) on Derivative Instruments, Net, Pretax, Total" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r119" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain Loss On Disposition Of Assets1", "terseLabel": "Net gain on sale of assets", "totalLabel": "Gain (Loss) on Disposition of Assets, Total" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfDerivatives": { "auth_ref": [ "r119", "r653" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.", "label": "Gain (Loss) on Sale of Derivatives", "negatedLabel": "Loss on issuance of derivatives", "terseLabel": "Loss on issuance of derivatives" } } }, "localname": "GainLossOnSaleOfDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r119" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Net gains from sale of property, plant and equipment", "totalLabel": "Gain (Loss) on Disposition of Property Plant Equipment, Total" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r279" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "terseLabel": "Settlement gain under selling, general and administrative expenses" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r29", "r233", "r235", "r242", "r247", "r602", "r634" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Total goodwill", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Goodwill", "totalLabel": "Goodwill, Total", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r243", "r245", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r119", "r234", "r239", "r246", "r247" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Impairment Loss", "negatedLabel": "Impairment loss related to goodwill", "negatedTerseLabel": "Impairment loss on goodwill", "terseLabel": "Impairment loss on goodwill", "verboseLabel": "Impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r101", "r132", "r184", "r188", "r192", "r195", "r198", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r549" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit (loss)" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss": { "auth_ref": [ "r266" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss recognized as a result of the initial and subsequent write-down of a long-lived asset's carrying amount to fair value.", "label": "Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss", "terseLabel": "Impairment loss related to property, plant and equipment" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset": { "auth_ref": [ "r260", "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount on the books of the entity of the impaired asset to be disposed of by a method other than sale.", "label": "Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset", "terseLabel": "Carrying amount of property, plant and equipment" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r119", "r258" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "negatedLabel": "Impairment loss on intangible assets", "terseLabel": "Impairment loss on intangible assets", "totalLabel": "Impairment of Intangible Assets (Excluding Goodwill), Total" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r119", "r258" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment Of Intangible Assets Finitelived", "negatedLabel": "Impairment loss related to intangible assets", "negatedTerseLabel": "Intangible assets, Accumulated impairment losses", "netLabel": "Impairment loss related to intangible assets", "terseLabel": "Intangible assets, Impairment loss", "verboseLabel": "Impairment loss on intangibles" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r119", "r261", "r266" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment Of Long Lived Assets Held For Use", "negatedLabel": "Impairment loss related to property, plant and equipment", "terseLabel": "Impairment loss on property, plant and equipment", "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total", "verboseLabel": "Impairment loss" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r119", "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment Of Long Lived Assets To Be Disposed Of", "terseLabel": "Property, plant and equipment impaired" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r94", "r184", "r188", "r192", "r195", "r198", "r633", "r645", "r655", "r675" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "terseLabel": "Loss before income taxes", "totalLabel": "Loss before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r14", "r15", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r269", "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r134", "r451", "r454", "r458", "r469", "r475", "r477", "r478", "r479" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r135", "r151", "r152", "r183", "r449", "r470", "r476", "r676" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "negatedLabel": "Income tax", "negatedTerseLabel": "Income tax expense", "terseLabel": "Income tax expense", "totalLabel": "Total tax recovery", "verboseLabel": "Total tax recovery" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxRecoveryExpenseDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants": { "auth_ref": [ "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax (expense) benefit from continuing operations attributable to government grants to the extent recognized as a reduction of income tax expense.", "label": "Income Tax Expense Benefit Continuing Operations Government Grants", "terseLabel": "Tax credits and grants" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 13.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.", "label": "Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary", "terseLabel": "Difference in statutory tax rates of foreign subsidiaries" } } }, "localname": "IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign exchange" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost", "terseLabel": "Non-deductible stock-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 14.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Income Tax Reconciliation Other Reconciling Items", "terseLabel": "Other permanent differences", "totalLabel": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount, Total" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r450" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "terseLabel": "Adjustments in relation to prior years" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase Decrease In Accounts And Other Receivables", "terseLabel": "Trade and other receivables" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase Decrease In Accounts Payable Related Parties", "terseLabel": "Trade and other payables" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Deferred Revenue", "terseLabel": "Deferred revenues" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxes": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.", "label": "Increase (Decrease) in Income Taxes", "terseLabel": "Income taxes paid" } } }, "localname": "IncreaseDecreaseInIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.", "label": "Increase Decrease In Income Taxes Receivable", "terseLabel": "Tax credits receivable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "terseLabel": "Inventories", "totalLabel": "Increase (Decrease) in Inventories, Total" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.", "label": "Increase Decrease In Operating Capital", "negatedLabel": "Changes in operating assets and liabilities", "totalLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r118", "r583" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase Decrease In Operating Lease Liability", "negatedLabel": "Leases" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase Decrease In Prepaid Expense", "terseLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r249", "r253" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets", "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total", "verboseLabel": "Total intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r566" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails": { "order": 0.0, "parentTag": "nept_FinanceCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest And Debt Expense", "negatedLabel": "Interest charges and other finance costs", "terseLabel": "Interest charges and other finance costs", "totalLabel": "Interest and Debt Expense, Total" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r91", "r182", "r565", "r569", "r654" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense", "totalLabel": "Interest Expense, Total" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r108", "r322", "r331", "r334", "r335" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails": { "order": 1.0, "parentTag": "nept_FinanceCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "negatedLabel": "Interest expense on loans and borrowings", "terseLabel": "Interest expense on loans and borrowings", "totalLabel": "Interest Expense, Debt, Total" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r652" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails": { "order": 0.0, "parentTag": "nept_FinanceIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income Expense Net", "terseLabel": "Interest income", "totalLabel": "Interest Income (Expense), Net, Total" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r46" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory Finished Goods", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r18", "r52", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories", "totalLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r48" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails": { "order": 0.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Raw Materials", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r47" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory Work In Process", "terseLabel": "Work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r229" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_CostOfGoodsAndServicesSold", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write Down", "negatedLabel": "Impairment loss on inventories", "terseLabel": "Impairment loss on inventories" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee Lease Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee Lease Description [Table]", "terseLabel": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee Operating Lease Liability Maturity Table [Text Block]", "terseLabel": "Summary of Maturity Analysis, Contractual Undiscounted Cash Flows" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease liabilities payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "2028 and thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r587" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails2": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Renewal Term", "terseLabel": "Renewal option" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract", "terseLabel": "Lease, term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r60", "r132", "r190", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r515", "r521", "r522", "r549", "r600", "r601" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r44", "r132", "r218", "r549", "r602", "r639", "r665" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r61", "r132", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r515", "r521", "r522", "r549", "r600", "r601", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "terseLabel": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r25", "r26", "r27", "r32", "r33", "r132", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r515", "r521", "r522", "r549", "r600", "r601" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities Noncurrent", "terseLabel": "Non-current liabilities", "totalLabel": "Liabilities, Noncurrent, Total" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r10", "r12", "r15", "r263", "r270" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Liabilities directly associated with assets held for sale", "totalLabel": "Liabilities directly associated with assets held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationScheduleOfMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Additional amount committed" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans Notes Trade And Other Receivables Disclosure [Text Block]", "terseLabel": "Trade and Other Receivables" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-Lived Assets by Geographic Areas [Table Text Block]", "verboseLabel": "Summary of Long-Lived Assets by Geographical Location" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r32", "r315", "r329", "r332", "r333", "r637", "r661" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long Term Debt", "totalLabel": "Total loans and borrowings" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Current And Noncurrent [Abstract]", "terseLabel": "Loans and borrowings:" } } }, "localname": "LongTermDebtByCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails": { "order": 0.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Current", "terseLabel": "Less current portion of loans and borrowings", "totalLabel": "Long-Term Debt, Current Maturities, Total" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long Term Debt Noncurrent", "terseLabel": "Loans and borrowings", "totalLabel": "Long-Term Debt, Excluding Current Maturities, Total" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-Term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r64", "r289" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-Term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsSummaryOfLoansAndBorrowingsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r279", "r280" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "periodEndLabel": "Loss Contingency Accrual, Ending Balance", "periodStartLabel": "Loss Contingency Accrual, Beginning Balance", "terseLabel": "Arbitrator's award with fees and cost including applicable interest" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r279" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Loss contingency accrual", "verboseLabel": "Settlement amount" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualProvision": { "auth_ref": [ "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.", "label": "Loss Contingency Accrual Provision", "terseLabel": "Provision" } } }, "localname": "LossContingencyAccrualProvision", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencySettlementAgreementDate": { "auth_ref": [ "r279", "r281", "r283" ], "lang": { "en-us": { "role": { "documentation": "The effective date of a duly executed litigation settlement agreement.", "label": "Loss Contingency, Settlement Agreement, Date", "terseLabel": "Settlement agreement date" } } }, "localname": "LossContingencySettlementAgreementDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input Exercise Price [Member]", "terseLabel": "Exercise Price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input Expected Dividend Rate [Member]", "terseLabel": "Dividend Yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input Expected Term [Member]", "terseLabel": "Remaining Contractual Life (Years)" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input Price Volatility [Member]", "terseLabel": "Expected Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input Risk Free Interest Rate [Member]", "terseLabel": "Risk Free Interest" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input Share Price [Member]", "terseLabel": "Share Price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r69", "r132", "r218", "r290", "r294", "r295", "r296", "r299", "r300", "r549", "r638", "r664" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Minority Interest", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "terseLabel": "Non-controlling interest", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Minority Interest Disclosure [Text Block]", "terseLabel": "Non-controlling Interest" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Minority Interest [Line Items]", "terseLabel": "Minority Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Minority Interest Ownership Percentage By Noncontrolling Owners", "terseLabel": "Minority ownership percentage", "verboseLabel": "Non-controlling interest percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interest Ownership Percentage By Parent", "terseLabel": "Acquired interest" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r69", "r102", "r510", "r520" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Minority Interest [Table]", "terseLabel": "Minority Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r115" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities:", "verboseLabel": "Cash flow from (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r115" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "terseLabel": "Cash flow used in investment activities", "totalLabel": "Net cash used in investing activities:", "verboseLabel": "Cash flow from investment activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r115", "r117", "r120" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "negatedLabel": "Cash flow from operations", "terseLabel": "Cash flow used in operating activities", "totalLabel": "Net cash used in operating activities", "verboseLabel": "Cash flow from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfCashFlowDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r15", "r81", "r84", "r89", "r95", "r120", "r132", "r143", "r145", "r146", "r147", "r148", "r151", "r152", "r158", "r184", "r188", "r192", "r195", "r198", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r537", "r549", "r646", "r669" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r81", "r84", "r89", "r151", "r152", "r517", "r524" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income Loss Attributable To Noncontrolling Interest", "terseLabel": "Non-controlling interest", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total", "verboseLabel": "Loss attributable to the subsidiary's non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income Loss Attributable To Reporting Entity [Abstract]", "terseLabel": "Net loss attributable to:" } } }, "localname": "NetIncomeLossAttributableToReportingEntityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "New standards and interpretations not yet adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": { "auth_ref": [ "r122", "r123", "r124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired1", "terseLabel": "Acquired property, plant and equipment included in trade and other payables" } } }, "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfNonCashTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": { "auth_ref": [ "r122", "r123", "r124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash Or Part Noncash Acquisition Intangible Assets Acquired1", "terseLabel": "Intangible assets included in trade and other payables" } } }, "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureSummaryOfNonCashTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r140", "r141", "r142", "r364", "r509" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Equity Attributable to Non-controlling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r107" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income Expense", "totalLabel": "Nonoperating income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.", "label": "Nonvested Restricted Stock Shares Activity Table [Text Block]", "terseLabel": "Summary of Number and Weighted Average Share Prices of Restricted Shares" } } }, "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number Of Businesses Acquired", "terseLabel": "Number of business acquisitions" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of segment" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r184", "r188", "r192", "r195", "r198" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "totalLabel": "Loss from operating activities" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r582", "r588" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost", "terseLabel": "Operating lease costs", "verboseLabel": "Non-cash lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r572" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Operating Lease Impairment Loss", "negatedLabel": "Impairment loss related to right-of-use assets", "terseLabel": "Impairment loss on right-of-use assets" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r574" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Lease liability", "totalLabel": "Total", "verboseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityAnalysisContractualUndiscountedCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r574" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails": { "order": 0.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Current portion of operating lease liabilities", "verboseLabel": "Current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease Liability Current Statement Of Financial Position Extensible List", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r574" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Operating lease liabilities", "verboseLabel": "Non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease Liability Statement Of Financial Position Extensible List", "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseLiabilitiesAmountsRecognizedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r578", "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "negatedLabel": "Operating cash flow payments for operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureLeasesSummaryOfMovementsInCashAndNoncashFlowsFromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r573" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r586", "r588" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted-average operating lease discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r585", "r588" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted-average remaining operating lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Tax losses carried forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityEquityAxis": { "auth_ref": [ "r337", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by type of options indexed to an issuer's equity.", "label": "Option Indexed to Issuer's Equity [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityEquityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r337", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed To Issuers Equity Type [Axis]", "terseLabel": "Option Indexed to Issuer's Equity, Type" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed To Issuers Equity Type [Domain]", "terseLabel": "Option Indexed to Issuer's Equity, Type" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r527", "r530" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r75" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Net change in unrealized foreign currency (losses) gains on translation of net investments in foreign operations (tax effect of nil for both periods)", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r75", "r78", "r553", "r562" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "terseLabel": "Unrealized foreign currency gains, tax effect", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r82", "r85", "r87", "r88", "r90", "r96", "r357", "r556", "r561", "r563", "r647", "r670" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Other comprehensive loss for the period", "totalLabel": "Total other comprehensive (loss) income", "verboseLabel": "Other comprehensive income (loss) for the period" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]", "terseLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r677" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails": { "order": 1.0, "parentTag": "nept_FinanceIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other finance income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFinanceIncomeAndFinanceCostsSummaryOfFinanceIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoriesSpareParts": { "auth_ref": [ "r49" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of components of assembled products that can be sold directly or indirectly through sales of assembled products.", "label": "Other Inventories Spare Parts", "terseLabel": "Supplies and spare parts" } } }, "localname": "OtherInventoriesSpareParts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesSummaryOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r65" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other liability" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Equity Attributable to Equity Holders of the Corporation" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PastDueFinancingReceivablesTableTextBlock": { "auth_ref": [ "r214", "r215", "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of aging analysis for financing receivable.", "label": "Past Due Financing Receivables Table [Text Block]", "terseLabel": "Summary of Aging of Trade Receivable Balances and Allowance for Doubtful Accounts" } } }, "localname": "PastDueFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Litigation settlement amount" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfWarrants": { "auth_ref": [ "r112" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.", "label": "Payments For Repurchase Of Warrants", "negatedLabel": "Issuance of shares and warrants costs" } } }, "localname": "PaymentsForRepurchaseOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related To Tax Withholding For Share Based Compensation", "terseLabel": "Withholding taxes paid to issuance of RSUs" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r109", "r505" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "terseLabel": "Business acquisition, cash transferred" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r110" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments To Acquire Intangible Assets", "negatedLabel": "Acquisition of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r110" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Acquisition of property, plant and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock Dividend Rate Percentage", "terseLabel": "Percentage of dividend issued on paid up capital" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r36", "r341" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Number of shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Number of shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r20", "r53", "r231", "r232" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense Current", "terseLabel": "Prepaid expenses", "totalLabel": "Prepaid Expense, Current, Total" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromInterestReceived": { "auth_ref": [ "r113" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest received on loans and other debt instruments during the current period.", "label": "Proceeds From Interest Received", "terseLabel": "Interest received" } } }, "localname": "ProceedsFromInterestReceived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r111" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds From Issuance Of Warrants", "terseLabel": "Proceeds from the issuance of shares and warrants through a Direct Offering", "verboseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds From Warrant Exercises", "terseLabel": "Gross proceeds from offering" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]", "terseLabel": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r279", "r282", "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]", "terseLabel": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r15", "r81", "r84", "r89", "r114", "r132", "r143", "r151", "r152", "r184", "r188", "r192", "r195", "r198", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r511", "r516", "r518", "r524", "r525", "r537", "r549", "r655" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "negatedLabel": "Net loss", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss for the period" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plant And Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r273", "r696", "r697", "r698" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Fair Value Disclosure", "terseLabel": "Fair value of property, plant and equipment estimated" } } }, "localname": "PropertyPlantAndEquipmentFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property Plant And Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment [Member]", "verboseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r265", "r602", "r656", "r666" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property, plant and equipment", "totalLabel": "Property, plant and equipment, net", "verboseLabel": "Total property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable Type [Domain]", "terseLabel": "Receivable" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": { "auth_ref": [ "r187", "r192" ], "lang": { "en-us": { "role": { "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.", "label": "Reconciliation of Revenue from Segments to Consolidated [Table]" } } }, "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r387", "r593", "r594" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r387", "r593", "r597", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r591", "r592", "r594", "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReportingUnitAxis": { "auth_ref": [ "r244", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Information by reporting unit.", "label": "Reporting Unit [Axis]", "terseLabel": "Reporting Unit" } } }, "localname": "ReportingUnitAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReportingUnitDomain": { "auth_ref": [ "r244", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Level of reporting at which goodwill is tested for impairment.", "label": "Reporting Unit [Domain]", "terseLabel": "Reporting Unit" } } }, "localname": "ReportingUnitDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r446", "r447" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research And Development Arrangement Contract To Perform For Others By Type [Axis]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r446", "r447" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.", "label": "Research And Development Arrangement Contract To Perform For Others Type [Domain]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r445", "r617", "r710" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "negatedLabel": "Research and development expenses", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and Development Expenses", "verboseLabel": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Common Shares" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r40", "r364", "r602", "r663", "r687", "r689" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "negatedLabel": "Accumulated deficit", "terseLabel": "Deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureReportingEntityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r140", "r141", "r142", "r144", "r150", "r152", "r219", "r439", "r440", "r441", "r467", "r468", "r535", "r684", "r686" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r180", "r181", "r187", "r193", "r194", "r200", "r201", "r206", "r369", "r370", "r618" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Revenue from contracts with customers", "totalLabel": "Revenue from sale of goods and services", "verboseLabel": "Revenue from sales, net of excise taxes of $641,877 (2021 - $140,620)" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.", "label": "Revenue From Contract With Customer Product And Service Extensible List", "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]" } } }, "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Summary of Revenue Attributed to Geographical Locations" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueNotFromContractWithCustomerOther": { "auth_ref": [ "r92" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue that is not accounted for under Topic 606, classified as other.", "label": "Revenue Not From Contract With Customer Other", "terseLabel": "Other revenues" } } }, "localname": "RevenueNotFromContractWithCustomerOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r93", "r132", "r180", "r181", "r187", "r193", "r194", "r200", "r201", "r206", "r218", "r290", "r291", "r292", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r549", "r655" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue", "totalLabel": "Total revenues", "verboseLabel": "Realized revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r584", "r588" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Operating lease right-of-use assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureLeasesSummaryOfMovementsInCashAndNoncashFlowsFromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Royalty Expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r173", "r206" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue Net" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]", "terseLabel": "Summary of Trade and Other Receivables" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block]", "terseLabel": "Summary of Trade and Other Payables" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherPayablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r491", "r492", "r499" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule Of Business Acquisitions By Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationSummaryOfFinalPurchasePriceAllocationOfAssetsAcquiredAndLiabilitiesAssumedParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule Of Cash Flow Supplemental Disclosures Table [Text Block]", "terseLabel": "Summary of Supplemental Cash Flow Disclosure" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSupplementalCashFlowDisclosureTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Income Tax (Recovery) Expense" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r64", "r138", "r332", "r334", "r358", "r361", "r362", "r363", "r567", "r568", "r571", "r657" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule Of Debt Instruments [Text Block]", "terseLabel": "Summary of Loans and Borrowings" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLoansAndBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Schedule of Components of Net Deferred Tax Asset (Liability)" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r14", "r15", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of Major Classes of Assets and Liabilities Classified as Held for Sale" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureBasisOfPreparationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Schedule of Reconciliation of Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]", "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureFairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": { "auth_ref": [ "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about aging analysis for financing receivable.", "label": "Schedule Of Financing Receivables Past Due [Table]", "terseLabel": "Schedule Of Financing Receivables Past Due [Table]" } } }, "localname": "ScheduleOfFinancingReceivablesPastDueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesSummaryOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule Of Goodwill [Table]", "terseLabel": "Schedule Of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureGoodwillSummaryOfAggregateAmountOfGoodwillIsAllocatedToEachReportingUnitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r24", "r49", "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Summary of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureInventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block]", "terseLabel": "Summary of Final Purchase Price Allocation of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r595", "r597" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r184", "r185", "r191", "r243" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r393", "r395", "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]", "terseLabel": "Summary of Number and Weighted Average Share Prices of RSUs" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]", "terseLabel": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]", "terseLabel": "Summary of Number and Weighted Average Exercise Prices of Market Performance Options" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r402", "r419", "r422" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Stock Option Plan" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]", "terseLabel": "Summary of Assumptions Used to Determine Fair Value of Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r35", "r36", "r37", "r129", "r169", "r170", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r346", "r350", "r355", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule Of Stock By Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r365", "r396" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]", "terseLabel": "Summary of Warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]" } } }, "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r176", "r178", "r179", "r184", "r186", "r192", "r196", "r197", "r198", "r199", "r200", "r205", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Operating Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegments1" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfAssetsHeldForSaleDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfLonglivedAssetsByGeographicalLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Revenue Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingRevenueReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueAttributedToGeographicalLocationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r106" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "negatedLabel": "Selling, general and administrative expenses, net of subsidies of nil (2021 - $64,299 )", "negatedTerseLabel": "Selling, general and administrative expenses", "totalLabel": "Selling, General and Administrative Expense, Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfLossAndComprehensiveLossDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling General And Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses", "verboseLabel": "Selling General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureBasisOfPreparationAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r35", "r36", "r357" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Shares" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r118" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Share-based payment", "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights", "terseLabel": "Description of vesting requirements for share-based payment arrangement" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Description", "terseLabel": "Terms and conditions of share based payment" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period", "negatedLabel": "Shares outstanding, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average share price, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Shares outstanding, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average share price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Shares outstanding, Ending balance", "periodStartLabel": "Shares outstanding, Beginning balance", "terseLabel": "Shares outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average share price, Ending balance", "periodStartLabel": "Weighted average share price, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "terseLabel": "Shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Expiration Date", "terseLabel": "Expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price", "terseLabel": "Exercise price and share price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-free interest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Options exercisable", "verboseLabel": "Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price, Options exercisable", "terseLabel": "Warrants exercisable, Weighted average exercise price", "verboseLabel": "Warrants exercisable, Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period", "negatedLabel": "Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Granted", "verboseLabel": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r403", "r405" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Options outstanding , Ending balance", "periodStartLabel": "Options outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r403", "r405" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, Options outstanding, Ending balance", "periodStartLabel": "Weighted average exercise price, Options outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Percentage of maximum number of stock options can be issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r398", "r399", "r400", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r421", "r423", "r424", "r427", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfDsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRestrictedSharesDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageSharePricesOfRsusDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentTables" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, Exercised", "terseLabel": "Share issue price per share", "verboseLabel": "Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]", "terseLabel": "Exercise Price Range" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]", "terseLabel": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit", "terseLabel": "Exercise price, lower range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options", "periodEndLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable, Ending Balance", "periodStartLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable, Beginning Balance", "terseLabel": "Weighted number of options exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options", "periodEndLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Ending Balance", "periodStartLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Beginning Balance", "terseLabel": "Number of options outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit", "terseLabel": "Exercise price, upper range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Estimated life (years)", "verboseLabel": "Estimated period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares", "terseLabel": "Number of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1", "terseLabel": "Weighted average exercise price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2", "terseLabel": "Weighted remaining contractual life outstanding" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentScheduleOfNumberAndContractualLifeOfOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued Price Per Share", "terseLabel": "Combined offering price", "verboseLabel": "Share issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r54", "r640", "r641", "r658" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short Term Investments", "terseLabel": "Short-term investment", "totalLabel": "Short-Term Investments, Total" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r127", "r139" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant accounting policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "Provincial/State" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r35", "r36", "r37", "r129", "r132", "r155", "r156", "r157", "r159", "r161", "r169", "r170", "r171", "r218", "r290", "r294", "r295", "r296", "r299", "r300", "r341", "r342", "r346", "r350", "r357", "r549", "r716" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r67", "r87", "r88", "r89", "r140", "r141", "r142", "r144", "r150", "r152", "r168", "r219", "r357", "r364", "r439", "r440", "r441", "r467", "r468", "r535", "r556", "r557", "r558", "r559", "r560", "r563", "r590", "r684", "r685", "r686" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r140", "r141", "r142", "r168", "r618" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureTradeAndOtherReceivablesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Stock Compensation Plan [Member]", "terseLabel": "Stock Option Plan" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r36", "r37", "r357", "r358", "r364" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period Shares Conversion Of Units", "terseLabel": "Stock issued during period, shares, conversion of units" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r36", "r37", "r357", "r364" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Shares issued during period, shares", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the number of shares issued.", "label": "Stock Issued During Period Shares Period Increase Decrease", "terseLabel": "Total contributions by and distribution to equity holders, shares" } } }, "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r36", "r37", "r357", "r364", "r409" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Exercised", "terseLabel": "Share options exercised, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfNumberAndWeightedAverageExercisePricesOfMarketPerformanceOptionsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureShareBasedPaymentSummaryOfStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r36", "r37", "r357", "r364" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Shares issued during period, amount", "verboseLabel": "Number of common shares purchased" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r37", "r42", "r43", "r132", "r216", "r218", "r549", "r602" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "terseLabel": "Equity holders of the Corporation", "totalLabel": "Total equity attributable to equity holders of the Corporation" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Shareholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r88", "r132", "r140", "r141", "r142", "r144", "r150", "r218", "r219", "r364", "r439", "r440", "r441", "r467", "r468", "r509", "r510", "r523", "r535", "r549", "r556", "r557", "r563", "r590", "r685", "r686" ], "calculation": { "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Total equity", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureNonControllingInterestSummarizedStatementOfBalanceSheetsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r130", "r342", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r356", "r364", "r366", "r534" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "Capital and other components of equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "auth_ref": [ "r357", "r364" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in stockholders' equity during the period.", "label": "Stockholders Equity Period Increase Decrease", "terseLabel": "Total contributions by and distribution to equity holders", "totalLabel": "Stockholders' Equity, Period Increase (Decrease), Total" } } }, "localname": "StockholdersEquityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r564", "r604" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r564", "r604" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r564", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r564", "r604" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureProvisionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r603", "r605" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfCashFlowsUnaudited", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary Of Operating Loss Carryforwards [Text Block]", "terseLabel": "Schedule of Tax Losses Carried Forward" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Summary Of Tax Credit Carryforwards [Text Block]", "terseLabel": "Schedule of Unused Federal Investment Tax Credits" } } }, "localname": "SummaryOfTaxCreditCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax Credit Carryforward [Line Items]" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureIncomeTaxesScheduleOfUnusedFederalInvestmentTaxCreditsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfTaxLossesCarriedForwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r370", "r377" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r370", "r377" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]", "terseLabel": "Recognized at a Point in Time" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Recognized Over Time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueDerivedFromSaleOfGoodsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfCostGoodOrServiceExtensibleList": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of cost from product sold and service rendered.", "label": "Type Of Cost Good Or Service Extensible List", "terseLabel": "Cost, Product and Service [Extensible Enumeration]" } } }, "localname": "TypeOfCostGoodOrServiceExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance By Deferred Tax Asset [Axis]", "terseLabel": "Valuation Allowance by Deferred Tax Asset" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfChangesOfDeferredIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Technique [Axis]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Technique [Domain]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsAdditionalInformationDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueOptionPricingModelMember": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating price of option.", "label": "Valuation Technique Option Pricing Model [Member]", "terseLabel": "Black-Scholes Option Pricing Model" } } }, "localname": "ValuationTechniqueOptionPricingModelMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfChangesInValueOfEquityDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfChangesInEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants And Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants And Rights Outstanding", "periodEndLabel": "Warrants outstanding, ending balance", "periodStartLabel": "Warrants outstanding, beginning balance", "terseLabel": "Warrant liability", "verboseLabel": "Warrants amount" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfChangesInValueOfLiabilityRelatedToWarrantsDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfReconciliationOfChangesInFairValueOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants And Rights Outstanding Maturity Date", "terseLabel": "Warrants expiring date", "verboseLabel": "Expiry date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails", "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfOutstandingWarrantsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants And Rights Outstanding Measurement Input", "terseLabel": "Warrants, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/Role_DisclosureLiabilityRelatedToWarrantsSummaryOfFairValueOfDerivativeWarrantLiabilitiesEstimatedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r154", "r161" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number Of Diluted Shares Outstanding", "terseLabel": "Weighted average number of common shares, diluted", "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r153", "r161" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Weighted average number of common shares, basic", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.neptunewellness.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "https://asc.fasb.org/topic&trid=2134446" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(4)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r230": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126982154&loc=d3e400-110220" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r366": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r444": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r479": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r508": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r526": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r589": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r599": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r605": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13(h))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r711": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r712": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r713": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r714": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r715": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r716": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r717": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)" }, "r718": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(3)" }, "r719": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1405" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r720": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1)(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" } }, "version": "2.1" }